





























Engineering neuronal networks with nanomaterials: 
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Graphene is a single atomic plane material consisting of sp2-hybridized carbon atoms with a 
hexagonal structural organization and characterized by unique properties such as high 
electrical conductivity, mechanical flexibility and optical transparency. Due to their peculiar 
features, graphene and its derivates have attracted an increasing interest for biomedical 
applications including drug and gene delivery, imaging and diagnostic or tissue engineering. 
However, using graphene-based nanomaterials (GBNs) in modern medicine, in particular 
neurology, needs a greater and deeper understanding of the cell-nanomaterial interactions.  
In this framework we focus on studying the impact of GBNs on the neuronal network and 
their ability in shaping synaptic transmission.  
First, we exploited 3D elastomeric scaffolds enriched with graphene to better understand 
the effects of this nanomaterial on the neural activity when interfacing neurons and 
synapses in the third dimension. Our results, using imaging techniques, show the ability of 
graphene to modulate the neuronal network formation in a 3D environment which might be 
due to modulations in the excitatory/inhibitory ratio.  
Afterwards we investigated the interactions between graphene oxide flakes with small 
lateral size (s-GO) and isolated amygdala neurons and synapses. Thus, we developed and 
characterized an in vitro model of amygdala network using immunofluorescence and 
electrophysiological techniques. When we acutely applied s-GO to these cultures, the 
nanomaterial was capable to selectively alter the glutamatergic excitatory activity. This 
peculiar interaction may be taken into account for exploiting s-GO as a novel tool to target 









1. Nanotechnology, Nanomaterials and Biology 
NANOTECHNOLOGY. The term “nanotechnology” was adopted the first time, within a 
scientific publication, by Norio Taniguchi in 1974. Today we refer to nanotechnology as 
technology and science that work with engineered devices or nanomaterials which have a 
functional organization on the nanometer scale, normally from 1 to 100 nm, at least in one 
dimension (Silva, 2006). Since most of biological entities and cellular components are in the 
sub-micrometric and nanometric range, nanotechnology has been more and more used in 
biomedical issues (Fig.1); in fact, for example, the diameter of the DNA double helix is around 
2 nm, hemoglobin’s diameter is around 5 nm and lipid bilayer surrounding cells has a 
thickness between 6 and 10 nm. The application of nanotechnology into biology and 
medicine is called bionanotechnology or nanobiotechnology.  
 
Figure 1. Relative sizes of different cells and biological components. Notice that several cell elements 
show nanometric and micrometric dimensions. 
NANOMATERIALS are described as low-dimensional structures with at least one dimension 
<100 nm (Biswas and Wu, 2005). Due to their unique electronic, optical and mechanical 
features, nanomaterials are nowadays more and more used in several application fields like 
electronics (Kang et al., 2015) , cosmetic (Borowska and Brzóska, 2015; Patil et al., 2015) and 
medicine (Chen et al., 2013; Oyefusi et al., 2014; Simões et al., 2015). Moreover, 




and flexibility in allowing surface functionalization (Garbayo et al., 2014; Kumar et al., 2017). 
In medicine, for instance, functionalized nanoparticles like nanoliposomes can be used for 
drug delivery (Kumar et al., 2017; Maurer et al., 2001). Nanoparticles offer the ability to pass 
biological barriers, such as the blood-brain or intestinal barriers (Lockman et al., 2003; 
Russell-Jones, 1999; Vinogradov et al., 2004), reach their designed target and act as 
therapeutic and imaging agents. The ability to engineer nanomaterials to reach targeted 
therapy is probably one of the most important features of nanotechnology. Also in 
neuroscience, the improvement in designing and synthesizing nanomaterials has been used 





2. Carbon-Based Nanomaterials and Biomedical Applications 
2.1 Carbon-Based Nanomaterials (CBNs): General Features  
In the periodic table, carbon is one of the most abundant and versatile elements; it forms 
different compounds that present completely distinct properties depending on the variety 
of its allotropes and structures. In fact, the valence orbitals of Carbon are able to hybridize 
in three different configurations: sp, sp2 and sp3. Moreover, a full range of dimensionally 
different allotropes can be obtained from Carbon; depending on its hybridization it is 
possible to have stable structure like nano-sized balls, 0 dimensions (0D), long thin tubes, 1 
dimension (1D), single layers, 2 dimensions (2D) and crystal, 3 dimensions (3D) (Fig.2).  
Diamond and graphite are common examples, with amorphous carbon, of naturally 
occurring carbon allotropes, while carbon nanotubes, fullerenes, nanodiamonds and 
graphene are obtained from synesthetic process.  Diamond for example, is characterized by 
carbon atoms hybridized purely in sp3 configurations whereas in graphite the hybridization 
is sp2. Synthetic carbon-based materials like carbon nanotubes or graphene, present carbon 
atoms hybridized with sp2 bonds. In this last case, the fourth electron in pz orbital, which is 
not taking part in the sp2 hybridization, will form a delocalized π bond able to move between 
carbon atoms. This free electron led to one of the most important hallmarks of these 









Figure 2. Five types of carbons allotropes. Fullerene (0D), carbon nanotube (1D), graphene (2D) and 




FULLERENE was discovered in 1985 by H. W. Kroto and colleagues. The most common 
fullerene presents an icosahedral and symmetrical structure, which is composed of 20 
hexagons and 12 pentagons where every carbon atom is linked to other three with sp2 
hybridization (Kroto et al., 1985). This compound is characterized by 60 carbon atoms (C60) 
are arranged in soccer ball shape. Fullerenes are considered zero-dimensional (0D) carbon 
materials, which exhibit very interesting chemical and physical features (Gaudiana and 
Brabec, 2008; Guldi and Prato, 2000; Jensen et al., 1996; Kirner et al., 2014). Fullerene 
presents excellent mechanical features, it is able to resist high pressures and then return to 
its original shape; these hallmarks make this carbon-based material harder than others, such 
as steal and diamond. Moreover, fullerene is characterized by notable optical properties and 
high electron affinity. (Dresselhaus et al., 1996; Ruoff and Ruoff, 1991; Thompson and 
Fréchet, 2008).  
CARBON NANOTUBES (CNTs) are one of the most studied nanostructures in the latest 
decades (Li et al., 2015b). Described by S. Iijima in 1991 (Iijima, 1991), they are nano-objects 
obtained from a graphene sheet rolled in a cylindrical structure, where the length/diameter 
ratio makes CNTs a 1-dimensional object (Iijima, 1991; Iijima and Ichihashi, 1993). Single-
walled CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) are the two most important and 
used forms in biomedical applications; the first presents a single cylinder structure while the 
second consists of different concentric SWCNTs. Since their features are depending on 
length, diameter and morphology of the carbon tube, but also on how the graphene sheet 
is twisted, SWCNTs and MWCNTs display different properties (Charlier, 2002; Gooding, 
2005; Thostenson et al., 2001). CNTs present remarkable properties, such as high 
mechanical strength and elasticity, great thermal, chemical and structural stability, high 
electrical conductivity and high surface area (Ajayan, 1999; Katz and Willner, 2004); due to 
these, CNTs are among the most studied carbon based material in several fields.  
CARBON QUANTUM DOTS (CQDs, C-dots or CDs), called also fluorescent carbon 
nanoparticles, were first accidentally discovered in 2004 by Xu and collaborators in the 
course of SWCNTs purification (Xu et al., 2004). They are described as small nanoparticles 
characterized by excellent properties like high conductivity and chemical stability, low 
toxicity and in particular a very strong photoluminescence emission and optical features. 
Components and structure of CDs define their distinct characteristics (Lim et al., 2015) and, 




materials. Due to their properties, these nanoparticles have been used to develop solid‐state 
nanostructured solar cells (Briscoe et al., 2015) , in photocatalytic energy conversion 
(Fernando et al., 2015), in sensing applications (Zhao et al., 2015) but also in bioimaging 
applications due to their great intrinsic fluorescence, from the visible up to the neat infrared 
(IR) (Li et al., 2012; Strauss et al., 2014). 
NANODIAMONDS (NDs). Diamond is a metastable carbon allotrope where the atoms are 
organized in a variation of the face-centered cubic crystal structure (Shao et al., 2004) and, 
it is  known to be characterized by the greatest hardness and thermal conductivity for any 
material. Said that, nanodiamonds are nanoscale-level size diamonds that were described 
during 1960s. Structures of NDs are very complex; in fact, they present an amorphous 
carbon shell and a diamond core where the average size of particles are around 4-5 nm 
(Aleksenskii et al., 1999). Different techniques have been used to synthesize nanodiamonds 
like detonation (Yeap et al., 2008) or ion irradiation of graphite (Daulton et al., 2001). Among 
all the properties, NDs are defined by high hardness, reflection index and thermal 
conductivity, they also present great stability at room temperature and an extremely high 
resistivity (Zhang et al., 2018).  
2.2 Biological Interaction of Carbon-Based Nanomaterials  
BIOCOMPATIBILITY of CBNs. In recent years, carbon-based nanomaterials have been 
attracting significant attention in nanomedicine due to their unique mechanical, electronic, 
thermal and optical properties (Chen et al., 2015; Mundra et al., 2014). For example, CNTs 
present great optical absorption in the near IR and photo acoustic properties, which allow 
CNTs to be potentially used in in vivo applications with a bio-imaging and tracing function 
coupled with drug delivery, or like nanodiamonds or fullerenes, which in the last few years, 
have been used in the cancer medicine area (Chen et al., 2015).  However, before describing 
the biomedical application of CBNs, it is important to take into account their toxicity. 
The first thing to underline is that graphene or CNTs, for example, are not single 
nanomaterials but groups, family of nanomaterials, which possess significant differences in 
terms of their chemical and physical features, like purity or surface functionalization, but 
also in their safety/toxicity profile; because of this, generalizations and categorizations about 
the toxicity of carbon-based materials  must be avoided. For biocompatibility evaluation of 




immune system (Farrera and Fadeel, 2015). In fact, this specialized system is extremely 
important to protect us from pathogens and other external intrusion.  
Mainly for CNTs, due to their great potential in biomedical applications, a large number of 
studies were performed to evaluate their effect on the immunity. For example, Pescatori 
and colleagues, reported that functionalized MWCNTs, after have being internalized and 
assessed the lack of toxicity in cell lines, were able to activate immune-related pathways in 
monocytes demonstrating that CBN may behave like specific cell immunostimulatory 
agents, opening great future perspectives for their application also as immunotherapeutic 
agents (Pescatori et al., 2013). It has been described that surface functionalization of CBNs 
such as CNTs and carbon nano-onions, led to a reduction of their inflammatory response, 
with an attenuation  of innate immune system recruitment (Yang et al., 2013b). 
Nevertheless, the CBNs and the immune system interaction may be also reciprocal, meaning 
that the immune cells can react to nanomaterials and degrade them (Bhattacharya et al., 
2013).  
BIOMEDICAL APPLICATIONS of CBNs. As stated above, carbon-based nanomaterials are 
characterized by excellent physical and chemical features that make them extremely useful 
and attractive in biomedicine, for diagnostic and therapeutic applications, as well as in 
regenerative medicine.  
In novel therapeutic developments, these materials may be exploited as gene or drug 
delivery carriers.  Among CBNs for drug vehicle, CNTs are the most studied. For this aim, 
drugs can be inserted into CNTs using non-covalent interactions, like for examples π-π bonds 
as shown for doxorubicin, a chemotherapy drug (Chen et al., 2015), while for hydrophilic 
drugs also covalent binding have been reported (Bhirde et al., 2009). CNTs can be used for 
gene or, more recently, small interfering RNA (siRNA) delivery (Al-Jamal et al., 2011) 
(Sacchetti et al., 2014), since CNTs are known to interact with DNA. Kostarelos and 
collaborators have supported a passive “nanosyringe-like” mechanism that can allow CNTs 
to permeate through the plasma membrane. The latter, if confirmed to be specific for the 
target cells, can be utilized for gene delivery (Kostarelos et al., 2007). In this context, since 
lipids, proteins or other biomolecules present in the biological environment, may rapidly 
coat the nanomaterial’s surface (so-called bio-corona formation), the potential impact of 




Other CBNs which have been studied as drug and gene delivery vehicles are fullerenes, 
particularly C60 (Dellinger et al., 2013). For example, Maeda-Mamiya and collaborators 
showed for the first time an effective gene delivery using a water-soluble fullerene in vivo 
(Maeda-Mamiya et al., 2010). These carbon materials, in addiction of being studied as 
vehicle, are nanoparticles that might be used as theragnostic tools per se. In particular, the 
metallofullerene nanoparticles are fullerene derivatives composed by a metal atom within 
a fullerene cage lately tested because of their peculiar mechanical and electrochemical 
features. Gadolinium (Gd)-based metallofullerenes are among them and have been 
proposed as new contrast agents and may also work like anti-cancer agents (Lu et al., 2012). 
Indeed, it has been showed that Cd-metallofullerenes are able to inhibit pancreatic tumor 
metastasis (Balogh, 2015; Kang et al., 2012; Pan et al., 2015). 
Moreover, nanodiamonds were recently proposed as new approaches able to bypass 
chemoresistance for metastatic cancer treatments; in fact, as reported by Chow and 
colleagues, nanodiamond-doxorubicin complex significantly enhances therapeutic response 
and reduces chemoresistance in mammary and liver cancer mouse models (Chow et al., 
2011).  
Another nanomedicine area, where CBNs received attention, is imaging and diagnostics. 
Also in this field CNTs are studied for multiple imaging modalities like Raman imaging, 
photoacoustic and fluorescence imaging and many others (De La Zerda et al., 2008; Delogu 
et al., 2012; Ghosh et al., 2014).  
C60 fullerenes, functionalized with metals, have been used as radiotracers and contrast 
agents, like for example metallofullerenes have been investigated for magnetic resonance 
imaging (MRI) for more than 10 years (Lu et al., 2012). Today CBNs have been used also to 
develop multi-functional theragnostic devices, where diagnostic and therapeutic modalities 
are combined (Chen et al., 2015). Shi and collaborators recently proposed a multifunctional 
nanoplatform to merge photodynamic and radiofrequency therapy and cancer diagnosis 
(Shi et al., 2014).  
Furthermore, also nanodiamonds are interesting instruments for imaging and diagnostic 
presenting intrinsic fluorescence features (Fu et al., 2007; Mochalin et al., 2012).  
New important tools for the biomedical research, that are becoming more and more 




electric and optical characteristics, may be combined into extremely sensitive probes and 
sensors (Wang and Dai, 2015). One example was presented by Iverson and colleges, where 
functionalized SWCNTs were used in vivo, to sense locally the concentrations of nitric oxide 
(NO), a molecule involved in physiological and pathological processes, without any immune 
reactions or different undesired responses. Moreover, they show that, since SWCNTs do not 
present photobleaching, no changes in their activity were observed after 400 days, 
underlining the very high stability of these carbon based sensors (Iverson et al., 2013).  
Finally, CBNs are valuable candidate for the growth of artificial scaffolds in tissue 
engineering,  to replace or repair damaged tissues (Ku et al., 2013). Physiologically, cells 
migrate and proliferate to compose tissues and organs within a special environment: the 
extracellular matrix (ECM). For this reason, synthetic scaffolds need to have physical 
structure and/or chemical composition reminiscent to the biological milieu (Keung et al., 
2010; Shin et al., 2003).  Due to their similar dimensions, carbon nanomaterials may provide 
physical analogues of ECM components, such as collagen fibers. CBNs, given their excellent 
mechanical properties, can reinforce inorganic and organic synthetic scaffolds and, 
moreover, their high electrical conductivity may be used to provide an electric stimulation 
to the artificial structure (Ku et al., 2013). One of the most used CBNs to develop tissue 
engineering scaffolds are carbon nanotubes, in fact CNTs present dimension diameter from 
1 to 100 nm in diameter, comparable to those of extracellular matrix elements. Indeed, 
experimental and theoretical data have shown that CNTs may ameliorate neural 
performance by promoting electrical “shortcuts” from the neuron cell body, or soma, to the 
dendrites (Cellot et al., 2009). Recently, Bosi and colleagues developed a self-standing, 
micro-porous, synthetic polymer-based scaffold to implement a 3-dimensional neuronal 
growth. Moreover, the authors entrapped MWCNTs within the scaffold, which allowed 
nanotubes to interact and boost cultured hippocampal neural circuits (Bosi et al., 2015). 
Further, it has been reported that nanodiamonds are able to act like a platform for neural 
growth (Thalhammer et al., 2010) whereas graphene-nanoparticles hybrid scaffold favored 




3. Graphene-Based Nanomaterials 
Graphene was discovered by Novoselov, (Nobel Prize in Physics in 2010), Geim and 
collaborators in 2004. It is a single atom thick, two-dimensional layers of carbon atoms 
hybridized in sp2 configuration with a hexagonal structural arrangement (Novoselov, 2004). 
One of the most exciting research field of graphene is centered on its nanoelectronic 
applications for next generation computer or sensing, as part of transistors or circuit 
elements (Ruoff, 2008). More recently, graphene research developed in a variety of 
engineering applications, including, for example, battery electrodes (Paek et al., 2009; Su et 
al., 2010), printable inks (Wang et al., 2010), conducting polymers (Stankovich et al., 2006) 
and supercapacitors (Dikin et al., 2007). Similarly to the case of CNTs, due to graphene’s 
excellent mechanical, chemical and electrical features, this CBM received increased 
attention in biomedical nanotechnology exploitation (Qu et al., 2018; Tonelli et al., 2015). 
This plethora of applications includes graphene (monolayer) and, increasingly, many 
graphene-related materials, called graphene-based nanomaterials (GBNs).  
3.1 Graphene Nanomaterial Family 
Graphene nanomaterials are classified based on lateral dimension, number of layers in the 
sheet, surface chemistry and their chemical composition.  
GRAPHENE or MONOLAYER GRAPHENE is, among all the GBNs, the compound that received 
the largest interest because of its properties (Geim, 2009). It is produced from graphite 
flakes by mechanical exfoliation or synthetized from non-graphite source via chemical vapor 
deposition (CVD) growth (Whitener and Sheehan, 2014). It is characterized by a large surface 
area, high thermal and electrical conductivity and mechanical flexibility (Kostarelos and 
Novoselov, 2014; Sanchez et al., 2012). Usually, in the absence of oxygen groups, it is highly 
hydrophobic.  
GRAPHENE OXIDE (GO) is the oxidized form of modified graphene. Most commonly, it is 
produced by acid-base treatment of graphite oxide (3D structure) followed by sonication. 
Different functional groups are present on the GO surface, among them, we can find oxygen 
epoxide groups but also carbonyl (=CO), hydroxyl (-OH) and phenol groups attached to the 
sheet edge. This nanomaterial shows on its surface reactive oxygen functional groups, 
negatively charged, making GO soluble in water and in other polar solvents (Paredes et al., 




other hand, GO shows decreased electrical conductivity that, using reducing agent, may be 
fixed up.  
REDUCED GRAPHENE OXIDE (rGO) was obtained by Stankovich and coworkers in 2007 by 
reducing GO with hydrazine (N2H4) for 24 h at 100° C (Stankovich et al., 2007). The intention 
of GO reduction is usually done to reestablish electrical conductivity but this procedure 
makes GO more hydrophilic and may lead to precipitates formation. The chemical reduction 
of GO can be obtained using many other chemical agents, such as sodium borohydride (Si 
and Samulski, 2008) or ascorbic acid (Zhang et al., 2010). Recently, Wang et al. fabricated 
high quality rGO with high electrical properties using thiophene (Wang et al., 2014).  
NANO-GO or GO nanosheet is a name to define small lateral dimension GO. Indeed, the 
stability of graphene oxide is size dependent. Usually nano-GOs are going from 5 to 50 nm 
size while graphene oxide sheets from 50 to 500 nm. GO nanosheets show a higher 
hydrophilicity due to the greater density of charges coming from the carboxyl ionized groups 
(-COOH) present on their edges (Luo et al., 2010). Increasing the ratio between surface and 
volume, nano-GOs display great dispersibility in water and organic solvents. This GBN is an 
excellent candidate for different biomedical applications (Compton and Nguyen, 2010).  
FEW-LAYER GRAPHENE (FLG) can be defined as a structure composed of 2-10 graphene 
layers originally obtained as a precursor or byproduct in the graphene monolayer production 
(Novoselov, 2004).  
3.2 Properties of GBNs 
Graphene-based nanomaterials present unique properties. Among all of them, some are 
more relevant for their biological exploitation such as surface area, lateral dimension, 
number of layers and surface chemistry.  
SURFACE AREA. Regarding biological interaction of nanomaterials, surely one important and 
central role is played by surfaces (Nel et al., 2009). In fact, small nanostructures (<10 nm) 
present on their surface a high part of their atoms exposed and they can mechanically and 
chemically interact with biological substrates. Single layer graphene is a peculiar case, 
because in this material every atom is placed on the surface and exposed to the surrounding 
environment on both sides. Also, monolayer GO presents a similar area even if the random 
attachment of oxygen on graphene surfaces leads to a disordered sheet and therefore 




to the increase number of layers.  In biological experiments, an important issue is to have a 
great stability of the surface area to avoid aggregates formation.  
LAYER NUMBER. In each GBN, the specific surface area and stiffness depend on the number 
of graphene layers present. In fact, the surface area is inversely proportional to the number 
of layers while the stiffness increases with the third power of the compound thickness or 
layers number. Single-layer graphene is one of the thinnest GBNs with a thickness around 
0.34 nm (Novoselov, 2004). Its hardness is greater than diamond because of the presence 
in the same plane of strong C-C bonds (Lee et al., 2008), whereas with diamond it can be 
deformed by low forces like water surface tension (Bellido and Seminario, 2010; Patra et al., 
2009). On the contrary, multilayers GBNs during their biological interaction can act like rigid 
bodies.  
LATERAL DIMENSION  i.e.  lateral size is very important to determine the maximum 
dimension of the nanomaterial, that is relevant for different biological phenomena 
depending on size such as cell uptake or blood-brain barrier (BBB) transport. The cellular 
uptake is susceptible to lateral dimension, with a maximum dimension of the material still 
going through phagocytosis or endocytosis. GBNs present a great range of lateral size, form 
the dimension of proteins, 10 nm, to more than the cellular size, >20 μm. Thus, because of 
their lateral dimension, GBNs can be internalized by cells (small GBNs), provide a support 
where adhering or spreading (large GBNs) but also represent a biological risk (Sanchez et al., 
2012).  
SURFACE CHEMISTRY. GBNs, even before any functionalization, present different surface 
chemistry. Single layer graphene, for example, is characterized by a hydrophobic surface and 
it requires specific modification to be applied in biological fluids. In contrast, GO surface is 
partially hydrophobic with hydrophilic area (Hsieh and Chen, 2011) and contains negative 
charges on the edge due to the presence of carboxylate groups (Cote et al., 2009). Due to 
its solubility in aqueous medium, much of the biomedical studies are done on GO 
nanosheets, even if it has been showed that long-term stability of GO in saline or culture 
medium requires specific functionalization (Feng and Liu, 2011; Sun et al., 2008).  
3.3 GBNs For Biomedical Applications 
In the last decade, graphene-based nanomaterials have attracted an increasing interest in 




bioelectrodes, bioimaging, biosensor and tissue engineering (Bitounis et al., 2013; Ding et 
al., 2015; Feng et al., 2013; Yang et al., 2013a). The attention to apply GBNs in the biomedical 
field is related to the remarkable features of these materials such as flexibility, mechanical 
properties, thermo-electrical conductivity, transparency and good biocompatibility. 
Potentially, GBNs might overwhelm the limitations of different metals, which are nowadays 
adopted for implantable devices, however characterized by low stability in long-time 
physiological environment, high inflammatory potential and stiffness (Bramini et al., 2018). 
Due to these evidences, several studies focused on applying GBNs in modern medicine and 
in particular in neurology where, one of the most ambitious goal is to develop new tools and 
technologies to treat central nervous system (CNS) disorders (neural regeneration, drug 
delivery, sensing and imaging) (Baldrighi et al., 2016; Kostarelos et al., 2017; Reina et al., 
2017). In particular, different studies have been done to investigate the interactions 
between GBNs and CNS such as using graphene-based electrodes for cell analysis (Li et al., 
2015a; Medina-Sánchez et al., 2012), for molecules delivery to the brain across the BBB 
(Dong et al., 2016; Tonelli et al., 2015) and graphene-based scaffolds for cell cultures (Li et 
al., 2013; Menaa et al., 2015). Moreover, it has been showed that the interaction among 
neural cells and GBNs may be very useful to study their electrical behavior or, by favoring 
controlled neural processes elongation, promoting neuronal regeneration (Fabbro et al., 
2016; Tu et al., 2014).  
3.3.1 Three-Dimensional GBNs-Based Scaffolds 
Tissue engineering points to reestablish the functionality of a damaged tissue by interacting 
it with proper biomaterials. This research field is nowadays in fast and great expansion due 
to the need of innovative strategy to reach greatly functional, biocompatible and low 
invasive implants for long time applications. In particular, when referring to the CNS, 
implantable devices can be very beneficial to stimulate and to record the neuronal electrical 
activity (Bramini et al., 2018). Between the devices that have been design and manufactured 
as neural interface there are deep brain stimulations implants (DBI), that allow to stimulate 
electrically deep CNS structures, used for example to treat tremors in Parkinson’s disease 
(Perlmutter and Mink, 2006); cochlear prosthesis able to transform external sounds in 
electrical signals (Spelman, 2006); neural interface systems to help people in motor 




2009) or in diagnostic, microfabricated electrodes to outline brain activity and signal 
processing (Chang, 2015). To define suitable neural implants several features are required 
such as good biocompatibility, low inflammatory response and avoiding the implanted tissue 
damage; moreover, if neural recordings are planned, a low signal-to-noise ratio is required. 
In this research field, GBNs characteristics can be exploited to develop new devices and 
improve the mechanical electrical and optical features of neural interfaces. Engineered 3D 
scaffolds is one of the most traditional applications of GBNs-based device in medicine that 
could be applied for in vitro or in vivo neuronal regeneration, for recording and stimulation 
or for drugs delivery (Cheng et al., 2017; Cong et al., 2014). 3D GFNs-structures can offer a 
controlled environment where cells can grow with geometries closer to the in vivo condition. 
Different 3D scaffolds have been developed and studied in vitro even if, up to now, just few 
of them have been tested also in vivo. For example, 3D flexible and porous rGO scaffolds 
were implanted in the injured rat spinal cord showing no local and systemic toxicity and the 
capacity of these devices to promote recovering tissue integrity after the lesion, even though 
uncapable to guide neural growth through it (López-Dolado et al., 2015). Moreover, rGO 
scaffolds chronically implanted were able to favor immunomodulation, angiogenesis but 
only partial regeneration of axons (López-Dolado et al., 2016). Different studies reported 
also how 3D graphene and GO structures can be compatible substrates for steam cells (Guo 
et al., 2016; Sayyar et al., 2016; Serrano et al., 2014). Beside the fact that within 3D 
graphene-based foams neural stem cells (NSCs) were able to growth, proliferate and 
differentiate into astrocytes and neurons, Li N. and collaborators showed how these 
structure were optimal stage to stimulate electrically the NSCs and improve their 
differentiation (Li et al., 2013). Not only NSCs but also dissociated hippocampal neurons have 
been cultured within 3D graphene-based scaffolds; as reported by Ulloa Severino et al., 3D 
neural cultures showed a more extended connectivity linked to a greater network 
synchronization if compared with 2D graphene structures (Ulloa Severino et al., 2016). To 
date the applications of 3D GBNs-based implants in neuroscience are still limited if 
compared with other biomedical area such as anticancer therapy (Xu et al., 2018), muscles 
(Mahmoudifard et al., 2016), guide bones (Lu et al., 2016) and cartilage regeneration (Nieto 
et al., 2015) but we expect the development and improvement of functional 3D GBNs-based 




3.3.2 Graphene-Based Nanosheets For Molecules Delivery 
GB nanosheets cytotoxicity. A different research branch of these nanomaterial applications 
is to use GBN nanosheets as drug per se or to delivery drug, gene or protein into the CNS 
bypassing the BBB. In literature, studies about the interaction between GB nanosheets and 
different cell types reported several common cytotoxicity mechanisms that include for 
example the physical interaction with cell membranes (Seabra et al., 2014), production of 
reactive oxygen species (ROS) that lead to oxidative stress (Mittal et al., 2016), DNA and 
mitochondrial damage (Fahmi et al., 2017; Pelin et al., 2017), but also necrosis and apoptosis 
(Lim et al., 2016). In the neuroscience area, several studies have been done using both 
neuronal-like cell lines (Lv et al., 2012) and primary cultures (Bramini et al., 2016; Rauti et 
al., 2016) but, to date, the interaction between neurons and glial cells and GB nanosheets is 
still not very clear primarily due to intrinsic features of these materials. In fact, the 
controversial biocompatibility of graphene-based nanosheets is related to the big 
heterogeneity of the available materials and the different methods of synthesis; due to 
these, nanosheets can be characterized by different size, aggregation state, chemical surface 
and thickness, which, as we said previously that can affect the interaction with biological 
systems.  
To date, based on previous findings it is apparent that GO is better tolerated than other 
graphene family materials like graphene or rGO and also that bigger nanosheets are more 
toxic than smaller one (Bianco, 2013; Ou et al., 2016); moreover, since GO presents great 
stability and solubility in biological fluids, it is preferred for biomedical studies (Reina et al., 
2017).  
GB nanosheets for molecule delivery. One important feature of GBNs is that their surface 
may undergo chemical functionalization and in this way it is possible to remodel their 
structure, for example, by adding hydroxyl, carboxyl, amino or other functional groups (John 
et al., 2015) and increase their biocompatibility degree. Moreover, the large surface area of 
GB nanosheets can host and carry also biomolecules such as drugs, antibody, genes and 
proteins (Chen et al., 2013). In fact, GB nanosheets might be used as a structure to deliver 
molecules to target cells, loading them via noncovalent functionalization like hydrophobic 





Figure 3. Schematic representation of noncovalent interactions of graphene and GO with different 
molecules: MoS2, aromatic polymers, proteins, core−shell nanoparticle, nanotube, quantum dot, 
ellipticine (drug/photoluminescence probe), DNA segment, and fullerenes (clockwise from top) (from 
(Georgakilas et al., 2016). 
For delivering molecules into the CNS, an important factor that must be taken into 
consideration is the blood-brain barrier. The BBB is one of the most important physiological 
barriers which purpose is to control and limit the entrance from the circulatory system into 
the brain of foreign materials and chemical substances. The neuroprotective function of BBB 
also blocks the crossing of drugs designed to reach target cells in the brain; in fact, from all 
the drugs that have been created for neuronal diseases only the 5% enters the CNS. In 
literature, several works have been published about the ability of GB nanosheets, 
functionalized or not, to bypass the BBB. For example, Mendonça and colleagues reported 
that intravenously administration of rGO in rats led to a downregulation of the tight and 
adherent junction proteins of the BBB and after that rGO nanosheets was found in the 
hippocampus (Mendonça et al., 2016a). The same group showed also that the PEGylation of 
rGO induced a toxic effect to the key components of BBB, like astrocytes and endothelial 
cells, in vivo (Mendonça et al., 2016b). A different approach to allow GB nanosheets to reach 
the brain is represented by the use of ultrasounds, which can physically open temporarily 
the tight junction of the BBB. Yang et al., using this method were able to deliver GO 
nanosheets, administered through tail vein injection, into the brain (Yang et al., 2014). An 
additional method is the functionalization of GB nanosheets surface with specific 




2015). The number of molecules/drugs that are successfully loaded to GB nanosheets is 
growing and one of the main applications is anticancer therapy where nanomaterials are 
linked to chemotherapeutics. Moreover GBNs, due to their optical properties, are been 
studying for diagnostic as attractive tools for bioimaging (Zhang et al., 2013). For all these 
reasons, GBNs delivery tool, if functionalized or associated with new technological approach, 





4. Three-Dimensional in vitro Neuronal Culture Models 
In vitro models are extremely important and useful tools to study and evaluate the cellular 
behavior in highly controlled conditions. Regardless of the extraordinary progress in tissue 
engineering and in bioengineering cell culture systems, two-dimensional (2D) cell culture 
continues to be the principal technique in the majority of biological studies. This is partly 
due to the fact that 2D cell culture are well characterized in literature and data are easily 
comparable; moreover, 2D samples are fast and simple to obtain and the techniques are 
definitely well set. However, 2D cell cultures present many limitations; first among all, cells 
that grow in 2D structures do not represent carefully the features of the three-dimensional 
(3D) tissue in vivo. In fact, cells are grown on flat surfaces, made of plastic or glass, which 
present unfamiliar mechanical properties and also the absence of the extracellular matrix 
support may lead to important changes in the growth, behavior and morphology of the cells 
(Bozza et al., 2014; Daud et al., 2012; Yano et al., 2015). To fill the gap between in vivo and 
2D in vitro conditions, new approaches have been developed such as 3D cell cultures. In 
neuroscience, 3D cell cultures preserve several good aspect of the in vitro model but with 
higher levels of cell survival, longer outgrowth of neurites and distinct patterns of 
differentiation if compared with 2D one (Blackshaw et al., 1997; Choi et al., 1993; Pardo and 
Honegger, 2000). Also, in 3D cultures, cells show a more spherical body and the processes 
have the possibility to spread in all directions (Fig.4). 
 
Figure 4. (Left). Visualization of cells for the three dimensions (X,Y,Z). In conventional 2D culture, cells 
grow as monolayers on a solid substrate; they flatten and possess a low vertical height. In contrast, 
cells cultured in a 3D model preserve a more physiological 3D structure and possess more normal 
dimensions all round. Moreover, the overall height (*) of a conventional 2D culture is relatively fixed, 
whereas that of a 3D culture is more versatile. Interactions between adjacent cells cultured in 2D are 




scope of intercellular contact is all around. (Right) Images acquired by confocal microscope of a single 
fibroblast grown in 2D or 3D culture. Scale bar: 10 μm (from Knight and Przyborski, 2015) 
3D models of the CNS can be obtained by explanted tissue cultures, self-assembled 
aggregate cultures and scaffolds-based cell culture (Ko and Frampton, 2016). Explanted 
culture can be obtained with techniques that enable to culture preserved tissues in vitro. 
This method permits to dissect the desired tissue from animals and to preserve the original 
3D architecture. Brain or spinal cord slices can be used fresh (acute slices) or they can be 
cultured in cell culture dishes using supporting membrane inserts (organotypic cultures) 
offering the possibility to study neuronal pathways, or nerve growth or neurological diseases 
(Navarro et al., 2016; Plenz and Kitai, 1996; Ravikumar et al., 2012). Self-assembled 
aggregate cultures exploit the natural propensity of cells to aggregate and they include 
spheroids, neurospheres and embryoid body which can be developed by different 
techniques including suspension cultures or using microwells (Choi et al., 2013; Dingle et al., 
2015; Ko and Frampton, 2016). Neural spheroids may be obtained either with primary cell 
cultures and cell lines, for example neuroblastoma cell lines (Besançon et al., 2012; Dingle 
et al., 2015). One important limitation of spheroids is the dimension that the cellular 
aggregate may reach; in fact, bigger is the cluster lower is the amount of nutrients and 
oxygen that can diffuse and reach the inner cells leading to necrosis of the center of the 
structure. However, this type of 3D culture is very common for studying tumors due to the 
fact that cell aggregates show good analogy to actual tumor tissue (Yano et al., 2015). In the 
other hand, spheroids present a fast rate of production and show a great potential for 
different applications like drug screening and toxicity testing (Choi et al., 2013).  
All the methods described above to develop 3D cultures are useful models to study various 
aspects of the nervous system, however they still present several limitations such as loss of 
connectivity, low gases diffusion and lack of control in the choice of the cell type. A different 
approach to develop 3D culture, which might overcome these limitations, is to use synthetic 
and/or natural biomaterial to create scaffolds where cells can grow and differentiate and 
reproduce a neural tissue in a very controllable system.  
4.1 Scaffold-Based Cell Culture: The Hippocampus 
In this thesis, I have been working with hippocampal cultures to characterize and develop 




Scaffold-based cell cultures exploit the presence of a 3D structure to recreate a cellular 
network with a 3D architecture. Nowadays, a great number of materials have been 
developed to engineer a 3D environment both natural such as agarose, collagen, laminin or 
synthetic like polycaprolactone, polyethylene glycol, polystyrene and polydimethylsiloxane 
(Ko and Frampton, 2016). Due to the big range of materials available the choice of the 
scaffold and its properties is very important and might affect several cellular functions and 
organization, and gene expression (Bozza et al., 2014; Li et al., 2007). In developing a scaffold 
for 3D culture there are different criteria that should be taken into consideration depending 
on the cell type we want to grow within it. To study in vitro neural system, dissociated 
hippocampal cultures have been popular for addressing and investigating neuronal 
processes and behaviors. Part of their popularity derives from their physiological relevance; 
hippocampus, for example, is one of the main sites for acquisition and storage of memory 
and it is also a part of the brain affected by neurodegenerative diseases. In addition, in vitro 
hippocampal network allows investigating synapses formation and functions; in fact, in the 
whole hippocampus, principal neurons send out recurrent collaterals that synaptically 
contact other pyramidal cells. Due to these features dissociated hippocampal cultures are 
an accessible and widely adopted model to study both physiological neuronal development 
and neurodegeneration (Hollenbeck and Bamburg, 2003). 
In terms of scaffold features, one of the most important is the porosity, in fact scaffolds for 
3D culture must present a strong but also porous structure where cells can adhere but also 
have the possibility to migrate and extend processes. The presence of pores is very 
important for the sufficient gases diffusion and medium perfusion to allow cell survival. The 
most used techniques to develop macroporous scaffolds are based on exploiting templates 
and molds that can be removed by dissolution or heat processes (Aurand et al., 2018; Bosi 
et al., 2015; Zhang et al., 2007). The pore size and the stiffness of the scaffold are also 
important and related with each other. In particular, the pore size must be correlated with 
the dimension of the selected cell type; in fact, pores should not be too small or too big to 
allow the formation of culture with a 3D architecture and at the same time to avoid cell 
clusterization and aggregation (LaPlaca et al., 2010). The charge of the 3D structure may 
influence the porosity and the cell behavior like in the study published by Dillon and 
coworkers where they showed that charged biopolymers affect the neurite outgrowth in a 




consideration is its stability during the time both for short and long-term cultures. In fact, 
the structure can go into degradation over time or may be modified by enzymatic reaction, 
especially when the scaffold is made of biomaterials like Matrigel (LaPlaca et al., 2010).  
4.2 Polydimethylsiloxane (PDMS) 
In the last two decades, the silicon-based elastomer polydimethylsiloxane (PDMS) has 
become very popular material for microfabrication and microfluidic devices in general but 
also, it has been more and more applied for in vitro biological applications (Gross et al., 2007; 
Meyvantsson and Beebe, 2008; Yeon and Park, 2007). This is due to its intrinsic properties 
and moreover because its simple fabrication procedures and pattern adjustability (Regehr 
et al., 2009). Among all its characteristics, PDMS is optically transparent, flexible and 
permeable to gases and it adhere to generally utilized substrates like glass; these make it 
suitable for microscopy and for long-term cell cultures. Moreover, the surface of pristine 
PDMS presents a remarkable hydrophobicity, mostly because of the presence of methyl 
groups; however this can be overcome using oxygen plasma treatment which, introducing 
hydroxyl groups, convert PDMS surface to hydrophilic (Zhou et al., 2012). Indeed, PDMS 
surface can be chemically functionalized but also enriched with materials such as 
nanoparticles (Bai et al., 2010) or CNTs (Han et al., 2013).  
Recently, PDMS has been used to fabricate 3D porous scaffold for in vitro 3D neural culture 







5. The Amygdaloid Complex 
In this thesis, I have developed 2D cultures from the amygdaloid complex to test sGO flakes 
ability to interfere with synaptic excitation in a neural system governing complex behavioural 
responses. 
5.1 Anatomy and Connection 
Despite the fact that human beings own a number of cognitive abilities that make a 
distinction between us and other animals, we share emotional behaviors — described as 
behavioral responses to emotionally relevant and vital stimuli such as food or threats — with 
other vertebrates.  
Amygdala is a region of the brain that is very important for emotional processing, of which 
circuitry and function have been reported to be well-conserved across evolution (Figure 5), 
even if differences within species do exist (McDonald, 1998). Indeed, also non-mammalian 
species such as birds, reptiles and fish present an amygdala-like brain region that shows 
similar circuits and functions to the mammal one (Jarvis et al., 2005; Johnston, 1923; Lanuza 
et al., 1998). 
 
Figure 5. Primary amygdalar nuclei and basic circuit connections and function are conserved across 
species. An enlarged image of the basolateral complex of the amygdala (BLA) and central nucleus of 
the amygdala (CeA) or analogues are shown next to a coronal section from the brains of a lizard, 




The amygdala is an almond-shaped structure nestled deep in the temporal lobe and was first 
described and named by the anatomist K.F. Burdach in the 19th century, who originally 
identified a group of cells that are known as the basolateral complex.  After that, in many 
species, a great number of structures have been described around the basolateral complex 
creating what is today known as the amygdaloid complex (Sah et al., 2003). 
The amygdaloid complex is structurally diverse and it is comprised of about a dozen nuclei. 
In turn, these can be divided into subgroups that have extensive connections, both 
internuclear and intranuclear. These nuclei and subnuclei are characterized by different 
cytoarchitectonic and connections they make (Krettek and Price, 1978). 
Three main groups or complexes of nuclei can be identified: 1) the deep or basolateral 
group, (BLA), which includes the lateral nucleus, the basal nucleus and basomedial nucleus; 
2) the centromedial groups, composed by the medial and central nuclei and 3) the superficial 
or cortical-like groups, which includes the cortical nuclei and the lateral olfactory tract 
nucleus. Moreover, a distinct set of nuclei do exist, which are listed apart because they do 
not fit within any of these groups, such as the amygdalohippocampal area and the 
intercalated cell masses (Sah et al., 2003). 
One traditional view is that the amygdala is composed of an evolutionary primitive part 
correlated with the olfactory system (the cortico-medial groups) and a recently developed 
division related with the neocortex (the basolateral region). Lately, it has been discussed 
that amygdala is not a functional or structural unit, however it consists of regions that belong 
to different regions or systems of the brain. Following this point of view, for example, the 
central and medial amygdala are suggested to be ventral expansion of the striatum while 
the basal and lateral nucleus instead of being regions related to the cortex, they are seen as 
a nuclear extensions of it (LeDoux, 2007).  
Indeed, morphologically, the neuronal composition of the BLA is similar to that of the 
cerebral cortex except for the fact that neurons are randomly oriented in the BLA. As in 
cortex, BLA contains two classes of neurons. The dominant group (~80%) consists of 
glutamatergic projection cells with multipolar dendritic trees covered with spines and axons 
contributing multiple collaterals to neighboring BLA cells, amygdala nuclei, or other 
structures of the brain. The second class of BLA neurons consists of local circuit GABAergic 




the CeA is a striatum-like that is constitute of GABAergic medium spiny neurons which 
project to different brain areas (Tovote et al., 2015).  
CONNECTIVITY. Amygdala nuclei and subnuclei show their unique inputs and outputs. Since 
describing all the amygdala connections is not the aim of this thesis I will mention just some 
key examples. The lateral amygdala is commonly identified as the gatekeeper of the 
complex, receiving sensory inputs from the visual, olfactory somatosensory and auditory 
area. However, different information reaches the amygdala through diverse nuclei (Figure 
6).  
 
Figure 6. Inputs to some amygdala nuclei. Abbreviations: B, basal nucleus; Ce, central nucleus; ITC, 
intercalated cells; La, lateral nucleus; M, medial nucleus. Aud, auditory; vis, visual; somato, 
somatosensory; gust, gustatory (From LeDoux, 2007). 
The central nucleus instead is one of the most important amygdala output nucleus where 
projection neurons synapse to brainstem areas that control physiological responses and 
specific behaviors (Figure 7). 
 
Figure 7. Outputs from some amygdala nuclei. Abbreviations: NE, norepinephrine; DA, dopamine; 
Ach, acetylcholine; 5HT, serotonin  (From LeDoux, 2007). 
The information from the lateral nucleus to the central one must travel through different 




central one. Moreover, the information might be delivered to the intercalated cells that are 
connected to the principal amygdala output. 
In addition to the central nucleus, different output connections start from the basal one 
(Figure 7). In fact, the latter is also connected with striatal areas implicated in the control of 
instrumental behaviors, like escaping to safety (LeDoux, 2007).  
5.2 Isolated Rat Amygdala Culture  
Over the past decades there has been an increase of interest in the amygdala complex 
mostly due to recent data on humans showing the role of the amygdala in determining the 
emotional meaning of sensory inputs (Adolphs et al., 1994; Scott et al., 1997) and in 
regulating the memory of emotionally eliciting stimuli (Cahill and McGaugh, 1998; Hamann 
et al., 1999). These functions are extremely important for successful managing in daily social 
surroundings (Morris et al., 1998). Knowing and understanding the roles of amygdala in 
human beings, however, is preceded by many laboratory works where are investigated the 
neuronal pathways and cellular mechanisms implicated in the emotional behavior of the rats 
(Gallagher and Holland, 1994). Regarding this, knowing the connectivity of the rat amygdala 
nuclei has been a key aspect in evaluating the hypothesis that were generated concerning 
the possible role of amygdala into different components of emotional behavior. Different 
works where electrophysiological activity were recording in various amygdala nuclei during 
a behavior task (Rogan and LeDoux, 1996) or where different nuclei were selectively 
lesioned (Killcross et al., 1997), has led to a further need for a deeper understanding of 
amygdala connectivity at molecular, cellular and functional levels. 
The simplest model that can be used to reach these goals is culturing in vitro isolated rat 
amygdala neurons. This in vitro model is an invaluable tool for investigating cell behavior and 
it has been using to characterize and describe molecular and cellular function in a very 
controlled setting (Kaneda and Akaike, 1989; Lin et al., 2001; McCool and Farroni, 2001; 
Meis and Pape, 1997). Moreover dissociated amygdala culture might be exploited for 
studying the chronic and toxic effect of different chemical compounds, like ethanol (McCool 





AIMS OF THE STUDY 
 
In the past few years, a growing number of studies were published showing the extensive 
applications of GBNs in the modern medicine and in particular in neurology. However, use 
of GBN in biomedicine requires a deeper understanding of the interaction between 
nanomaterial and neuron in terms of cell responses or cellular uptake. In fact, due to the 
unique properties that GBNs possess, these materials, interacting with cellular and 
subcellular components, might modulate important biological processes.  
The major aim of my work has been to understand the impact of nanomaterials on the 
neuronal network and in particular to study the ability of GBNs in shaping the synaptic 
activity by various physiological methods.  
During the first part of my PhD, we exploited elastomeric 3D scaffolds functionalized with 
single layer graphene to evaluate the effects of this nanomaterial, combined together with 
the 3D architecture, on the neuronal network dynamics. In fact, a better understanding of 
graphene ability to alter the neuronal activity in a 3D environment will allow to develop and 
design future devices for tissue engineering.  
We were able to recreate genuine 3D hippocampal cultures within the scaffolds, with and 
without graphene. Thus, we evaluated the synaptic activity of neurons grown in the two 
conditions and we described the graphene capability to perturb neural circuits maturation 
using imaging techniques.  
Recently, graphene oxide flakes characterized by small lateral size (s-GO) have been 
reported to alter selectively the glutamatergic synaptic activity of hippocampal neurons 
(Rauti et al., 2016, 2019).  This selective and precise interaction with the neuronal signaling 
in the CNS might lead to design novel neuropharmacological tools that can be exploited 
when the excitatory synapses are the desired target. In this regard, anxiety related disorders 
(ArDs), including for example post-traumatic stress disorders, are diseases which present 
alterations in the amygdala neuronal circuits; in particular they are characterized by a 
glutamate hyperactivity in the excitatory synapsis of amygdala neurons (Cortese and Phan, 
2005; Ganella and Kim, 2014; Wierońska et al., 2011). 
For all these reasons we designed a project which aim was to study the interaction, at the 




characterized amygdala dissociated cultures through electrophysiological and 
immunofluorescence techniques and subsequently we explored whether s-GO ability in 
targeting selectively hippocampal glutamatergic synaptic transmission might be translated 
in different neuronal models.  
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Abstract  
2D cultures are useful platforms allowing studies of the fundamental mechanisms governing 
neurons and synapse functions. Yet, such models are limited when exploring the 
contribution on networks dynamics of circuit topology, when neuronal branches can 
navigate in the 3D-space. 3D platforms fill this gap and favor investigating topologies closer 
to the real brain organization. Graphene, an atom-thick layer of carbon, possesses 
remarkable properties and since its discovery has been considered highly promising in 
neuroscience developments. Here, we exploit elastomeric 3D platforms endowed with 
graphene cues to modulate, by interfacing graphene in 3D topology, neuronal circuits. We 
successfully reconstructed ex-vivo neuronal networks within 3D scaffolds, with and without 
graphene, characterized by comparable size and morphology. By confocal microscopy and 
live imaging we documented the 3D architecture of synaptic networks sustaining high rate 
of bursting in 3D scaffolds, an activity further increased by graphene interfacing. We report 
changes in the excitation/inhibition ratio, potentially following 3D-graphene interfacing. We 
thus propose a hypothesis, where the combination between synapse formation under 3D 
architecture and graphene interfaces affected the maturation of GABAergic inhibition, 
tuning the balance between hyperpolarizing and depolarizing responses, and potentially 




The brain ability to elaborate and store information relies on neural circuits topology, that is 
the way neurons are synaptically connected in a given network. The architecture of neural 
connectivity, therefore, is one of the crucial mechanisms enabling the emergence of a 
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particular function from specific brain circuitries.[1] Investigating the interplay between 
morphology and function in brain networks is an important yet challenging task limited, for 
example, by the overwhelming complexity of the intact Central Nervous System (CNS). 
Recently, the development of biomimetic 3D scaffolds has allowed to culture neuronal and 
glial cells within an interconnected porous structure, promoting the development of more 
complex three-dimensional organizations of neuronal synaptic networks than in traditional 
monolayer conditions.[2,3] We recently developed a 3D versatile platform that provides a 
biocompatible cellular elastomeric scaffold to be engineered for tissue formation, that we 
further nanostructured with nano-topographies by means of multi walled carbon nanotubes 
(MWCNTs).[2,4] Decorating the elastomeric structure with nanomaterials exploits the 
scaffold properties at the interface, for example guiding growth and adhesion of axons to 
the device or implementing the 3D construct of active components, such as electrically 
conductive pathways.[4] In addition, apart MWCNTs,[2,5-7] many other carbon-based 
nanomaterials, as for example graphene,[8] may provide artificial biomimetic cues able to 
affect synapse formation or neuronal information processing through the physical 
interactions of the nanomaterial with the biological environment. Hybridizing 3D biomimetic 
scaffolds with nanomaterials demonstrated to improve their biocompatibility,[9] their 
stability in vivo,[4] and provides efficient tools to modulate biological processes.[4,8] 
Graphene, a single atomic plane material made of sp2-hybridized carbon atoms, is 
characterized by peculiar properties, including high electrical conductivity, stiffness, 
electron mobility, mechanical flexibility and optical transparency.[10-13] The recent exploiting 
of graphene as component of neural interfaces relies on the combination in a single material 
of all these features.[14]  
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In neuroscience, flat graphene substrates has shown to promote axon sprouting and 
outgrowth,[15] to reduce tissue inflammatory responses[16,17] and, surprisingly, to enhance 
neuron electrical signaling,[8,18] highlighting its potential as a tool for engineering neuronal 
interfacing devices.[14,17,19-22] The translation of graphene capability to perturb neuronal 
network activity from 2D to 3D represents the next step in the design of artificial platforms 
for tissue engineering. Only a few studies report how graphene-based 3D constructs, yet 
with diverse graphene derived materials (from graphene foams to graphene oxide scaffolds), 
interact with biological tissue/cells and how the interfaced neuronal network responds when 
exposed to graphene in 3D.[3,13,23,24] However, a detailed characterization of neural circuit 
adaptation to a 3D graphene environment is currently missing. Here, we took advantage of 
self–standing elastomeric scaffolds, characterized by a micro-porosity able to shape a 
functional 3D neuronal network,[2] to create a condition where neuronal cells could interact 
with single layer graphene in a genuine three-dimensional environment. We studied 
intracellular calcium activity in neurons within 3D hippocampal cultures that differed only 
by their being interfaced to graphene or not providing evidence that, despite the similar 
cellular composition and morphology of the resulting 3D neuronal networks, graphene has 
the ability to alter the synaptic inhibitory control of the network emerging activity. 
Surprisingly this effect seems intrinsic of the 3D topology since in 2D it is not present. 
2. Results  
2.1 Fabrication and characterization of 3D-scaffolds 
We present here a micro-porous, self-standing elastomeric-scaffold whose facets are 
covered by graphene and able to sustain the development of a genuine 3D-network of cells 
from rat hippocampus. Control 3D scaffolds consisting of polydimethylsiloxane (PDMS) 
alone were fabricated following a previously described procedure.[2,4] Briefly, the scaffold 
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was made of PDMS with micrometric cavities generated by the dissolution of a sugar 
template after that all interstitial space was previously embedded by the elastomer and 
cured. To exploit the ability of graphene to impact a three-dimensional neuronal circuit, the 
pristine 3D PDMS scaffold fabrication procedure was then modified by mixing few-layer 
graphene flakes with the sugar. This produces an agglomerate with graphene flakes layered 
on all sugar grains’ faces. After PDMS infiltration and curing, sugar dissolution leaves 
graphene flakes partially embedded, and consequently trapped, at the surface of the PDMS 
scaffold resulting in 3D PDMS-Graphene (3D-PDMS-GR) samples. The starting graphene 
flakes were fully characterized by TGA, Raman spectroscopy, and TEM (Figure 1, A-C). A low 
number of defects/functional groups characterize the graphene surface as pointed out by 
TGA analysis (Figure 1A) while Raman spectroscopy shows a ratio between the intensities of 
D and G bands (ID/IG) of 0.42 (Figure 1B). These two results indicate that the starting 
graphene material consist of about 4 layers graphene flakes.[25-27] TEM analysis, on the other 
hand, shows that the distribution of lateral dimensions of the flakes, based on a gaussian fit, 
is centered around 304 ± 124 nm (Figure 1C). 
The presence of graphene flakes trapped within 3D PDMS-GR was assessed by Raman 
spectroscopy. An example of a typical Raman profile acquired within a pore of a 3D PDMS-
GR scaffold is displayed in Figure 1D (average of 25 consecutive spectra) where graphene 
characteristic tangential (G, ~1580 cm-1), disordered (D, ~1350 cm-1) and second order (2D, 
~2700 cm-1) peeks are clearly visible,[28] together with two very intense bands around 3000 
cm-1 which correspond to the methyl stretching vibrations (symmetric and asymmetric) of 
the PDMS.[29] In Figure 1E we show a 3D mapping of the G-band intensity within a 
parallelepiped extending from the surface of the scaffold to 10 µm in depth by steps of 1 
µm. A total of 4290 spectra were represented in the 3D representation and a color code was 
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chosen to represent G-band intensity (red for higher intensities). From this, we were able to 
chemically visualize graphene on PDMS scaffold facets confirming the presence of 
homogeneous distribution of graphene flakes trapped within the scaffold surface. 
We aimed at a system developed to allow the growth (within a three-dimensional 
environment) of a neuronal network directly interfaced to graphene and, at the same time, 
soft enough to resemble the compliance of neural tissues. Using a high-resolution 
compressive load-cell we measure, by uniaxial-load compression test (see Methods), an 
indicative E value of 59.10 kPa for the 3D PDMS scaffold and of 58.82 kPa for the 3D PDMS-
GR one (Figure 1F). The two values, obtained calculating the initial linear slope of the 
corresponding stress-strain curve, are very similar, highlighting the absence of alterations in 
the bulk mechanical properties due to the superficial layering of graphene. 
The electrical characterization (see Methods) of the graphene enriched PDMS scaffold was 
performed as function of scaffold deformation squeezing the sample between two 
conductive, flat, electrodes (Figure 1G, left). Our analysis pointed out the necessity to induce 
at least a 20% deformation in the 3D PDMS-GR scaffold to start having a measurable value 
of resistivity (4.7 GΩ·mm). Not surprisingly, resistivity value decreased monotonically as 
deformation was increased, reaching a final value of about 2.7 MΩ·mm at 60% deformation 
(Figure 1G, right plot).  
The general morphologies of both 3D PDMS and 3D PDMS-GR scaffolds were compared by 
scanning electron microscopy (SEM) reconstructions (Figure 2A, left and right, respectively). 
SEM analysis revealed very similar morphologies for the two scaffolds and showed that sugar 
crystals dissolution generates faceted interconnected pores, which allow networks of 
channels within the PDMS matrix. The diameter of the pores within the two scaffolds was 
evaluated in the range of 100÷200 μm in both conditions except that in 3D PDMS-GR 
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scaffolds their surface is covered by a thin layer of graphene flakes, as pointed out by Raman 
spectroscopy (Figure 1D and 1E). 
2.2 Self-standing PDMS scaffolds sustain hippocampal cells growth in 3D: functional impact 
of few-layer graphene 
To investigate the development of neuronal networks when interfaced in the third 
dimension to graphene, we seeded rat dissociated hippocampal cells in the two elastomeric 
micro-porous scaffolds,[2,30] named 3D PDMS and 3D PDMS-GR, whose structure and 
porosity are shown in the representative SEM images of Figure 2A. The cell composition and 
3D organization of cultured hippocampal tissues within the two scaffolds were assessed 
after 9÷11 days in vitro (DIV) by confocal microscopy of β-tubulin III and glial fibrillary acidic 
protein (GFAP) immunofluorescence labeling, to visualize cytoskeletal components selective 
for neurons and astrocytes, respectively (Figure 2B).[31-34] In all cultures tested for confocal 
reconstruction (n = 8 for 3D PDMS and n = 7 for 3D PDMS-GR), prior to microscopy analysis, 
neuronal calcium activity was monitored (see below) and at the end of each recording 
session, the samples were fixed and processed for microscopy. Representative confocal 
micrographs at low (Figure 2B, first row) and high (Figure 2B, second row) magnifications 
highlight the formation of a genuine 3D configuration of neurons and glial cells when 
developed sustained by the 3D PDMS (left) and 3D PDMS-GR (right) scaffolds. To highlight 
the three-dimensional networks topology into the two porous scaffolds we extrapolated 
from the 3D confocal images obtained by zeta stacking, the zeta profile reconstructions 
(Figure 2B, bottom panels). In both conditions (3D PDMS and 3D PDMS-GR) an effective 
growth along the z axis is depicted confirming that these scaffolds promote three-
dimensional cellular networks formation, where neurons and glial cells are disposed on 
different levels, as also disclosed by cell nuclei distribution (in blue).[2,30] We further 
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quantified the hippocampal cell density which did not differ in the two conditions for both 
neurons (3D PDMS: 262.3 ± 29.2 β-tubulin positive cells/mm2; 3D PDMS-GR: 227.9 ± 16.4 β-
tubulin positive cells/mm2) and astrocytes (3D PDMS: 146.8 ± 18.6 GFAP positive cells/mm2; 
3D PDMS-GR: 118.4 ± 9.2 GFAP positive cells/mm2; n = 28 visual fields in 3D PDMS and n = 
23 visual fields in 3D PDMS-GR, four independent culture series; bar plots in Figure 2C). 
Biocompatibility together with the ability to instruct a 3D culture formation were thus 
confirmed for the 3D PDMS platforms and our results suggest that decorating scaffold pores’ 
surfaces by a thin film of few layer graphene flakes did not alter the resulting cellular 
network in size and morphology.[2] 
Primary cultured neurons once reorganized ex vivo in 3D scaffolds are known to develop 
functional synaptic connections and circuits characterized by the spontaneous generation 
of temporally structured electrical activity.[2] We explored the network dynamics in 3D PDMS 
and 3D PDMS-GR by calcium imaging with fluorescent indicators, this is a minimally invasive 
approach that allows monitoring calcium transients in neuronal populations at single-cell 
resolution.[2,3,30,35] Neurons, stained with the membrane permeable Ca2+ dye Oregon Green 
488 BAPTA-1, were simultaneously visualized within the sampled area (visual field 680×680 
μm2; Fig. 3A, left fields of view) and on average 30 ± 12 fluorescent cells were isolated and 
imaged in each visual field (see Methods). In these recordings, repetitive and spontaneous 
Ca2+ events were detected in 77% (555 out of 723 neurons, n = 23 visual fields, 3D PDMS) 
and, similarly, in 79% (705 out of 894 neurons, n = 24 visual fields; 3D PDMS-GR cultures) of 
visualized neurons. In Figure 3A, right, sample tracings of spontaneous fluorescent 
recordings from active cells are depicted for comparison between 3D PDMS (in green) and 
3D PDMS-GR (in red) cultures. Spontaneous and bicuculline (10 μM; a competitive 
antagonist of GABAA receptors) sustained activity of two representative cells were shown 
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for each condition. Calcium events are usually due to spontaneous episodes of synaptic, 
action potential-dependent, bursts of activity, fully blocked by Tetrodotoxin (TTX, 1 μM; a 
blocker of fast voltage dependent Na+ channels; see Methods) applications. We quantified 
the occurrence of spontaneous Ca2+ episodes in active cells by measuring the inter-event 
interval (IEI), the time interval between the onset of a calcium burst and the beginning of 
the next one, that was significantly (*** p < 0.001; Kolmogorov-Smirnov test) shorter in 3D 
PDMS-GR cultures (9.8 ± 0.18 s, n = 175 cells, from 5 different series of cultures) when 
compared to 3D PDMS ones (12.7 ± 0.23 s, n = 208 cells, from 5 different series of cultures; 
see the IEI cumulative distribution in Figure 3B, left plot). We further quantified network 
synchronization by evaluating the mean Cross Correlation Factor (CCF; see Methods) of 
spontaneous calcium episodes. 3D PDMS cultures displayed a CCF value of 0.48 ± 0.04 (n = 
14 fields) significantly (** p < 0.006, Mann Whitney test) smaller than the value detected in 
3D PDMS-GR (CCF 0.66 ± 0.04; n = 13 fields), indicative of a higher synchronization among 
active neurons when interfaced to graphene in the third dimension. All these results suggest 
an increased neuronal excitability or diverse paths of neuronal interconnection, for example 
displaying a lower synaptic inhibition, when neurons are interfaced to graphene in 3D 
constructs. 
In neuronal circuits, the ratio of excitatory and inhibitory inputs to a cell usually regulates 
the balance between excitation and inhibition. To gain insights into the GABAergic inhibitory 
control of the neural circuits developed in the two 3D scaffolds, we compared network 
activity upon pharmacological block of GABAA receptors by bicuculline (10 μM) application. 
In neural networks, the removal of GABAergic synaptic component is known to alter the 
emerging activity patterns,[2,36,37] leading to a more intense and regular bursting.[2,35,38] 
Figure 3A (right dotted traces), shows samples of fluorescence tracings of active cells in the 
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presence of bicuculline (similar results were obtained by gabazine applications, see 
methods). As expected, regular Ca2+ events were detected in both culturing groups, 
characterized by IEI of 8.0 ± 0.05 s in 3D PDMS cultures (n = 218 cells), a value significantly 
(*** p < 0.001; Kolmogorov-Smirnov test) lower when compared to that of 3D PDMS-GR 
14.2 ± 0.2 s, n = 175 cells; all data summarized in the cumulative distribution in Figure 3B, 
right plot). Disinhibited activity was defined, in both groups, by comparable, although higher 
than in control, CCF values (3D PDMS CCF 0.75 ± 0.03; 3D PDMS-GR 0.81 ± 0.03, data not 
shown), strengthening the hypothesis that the higher calcium episodes occurrence in 
standard saline solutions when 3D PDMS-GR cultures are compared to 3D PDMS, might 
indicate a diverse contribution of the GABAergic drive to the network activity in the two 
groups.  
To ascertain whether the observed changes in network dynamics emerged from the sole 
presence of graphene, independently from the 3D growth conditions, hippocampal cultures 
were grown on flat coverslips covered by a thin layer of graphene flakes (2D GR, see 
Methods) and the emerging activity was compared to cells grown on flat glass coverslips 
(CTRL). In standard saline solution, we detected 44% spontaneously active cells in 2D control 
conditions, increased to 52% in 2D GR. Figure 4A (left) shows representative visual fields of 
fluorescent cells and representative fluorescent tracings (right) of spontaneous and 
bicuculline-induced neuronal activity (dotted traces) recorded from 2D CTRL (top) and 2D 
GR (bottom) cultures. When we measured Ca2+ activity, the IEI was significantly (*** p < 
0.001; Kolmogorov-Smirnov test) lower in 2D GR cultures (9.2 ± 0.16 s, n = 185 cells, from 3 
different series of cultures) when compared to control ones (14.7 ± 0.28 s, n = 232 cells, 
from 3 different series of cultures; see cumulative distributions in Figure 4B, left plot), in line 
with the reported increase in neuronal activity when cultures grow interfaced to single-layer 
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graphene.[8] The trend in terms of IEI in 2D graphene was preserved also in the presence of 
bicuculline (13.4 ± 0.09 s, n = 258 cells, control; 7.4 ± 0.07 s, n = 197 cells, 2D GR; ***p < 
0.001; see cumulative distribution in Figure 4B, right plot). These results suggest that 
neurons when interfaced to graphene increased their activity but, differently from the 3D 
condition, the inhibitory control of the network was unaltered by graphene interfacing. 
To acquire a better understanding of our observations, we investigated whether the 3D 
PDMS-GR scaffolds affected the development of inhibition in resulting 3D neuronal circuits 
by considering two hypotheses. First, graphene might have changed the ratio of excitatory 
to inhibitory neurons altering the expression of the GABAergic neuronal phenotype. To 
validate this possibility 3D cultures developed inside 3D PDMS and 3D PDMS-GR scaffolds 
were co-immunostained with β-tubulin III and anti-GABA and processed by confocal 
microscopy (Figure 5A left and right images, respectively). By quantifying the percentage of 
double positive cells, i.e. GABAergic neurons, for the two conditions we discovered that the 
two values were similar for 3D PDMS (40.3%, n = 27 visual fields, from 4 different series of 
cultures) and for 3D PDMS-GR (43.2%, n = 25 visual fields, from 4 different series of cultures; 
summarized in the bar plot of Figure 5B).   
The second hypothesis we investigated was that 3D PDMS-GR could have affected the 
maturation of GABAergic inhibition via tuning chloride ion fluxes through GABAA receptors. 
It is in fact well known that during CNS development, neuronal intracellular chloride 
concentration shifts from higher to lower values (with respect to the extracellular one), 
modulating the amplitude of GABAergic currents.[39,40] In accordance, in immature neurons, 
GABAA receptors activation may result in a depolarization contributing to network 
bursting.[41] We performed chloride imaging using a quinoline-based Cl– indicator dye: MQAE 
(N-[6-methoxyquinolyl] acetoethyl ester).[8,42]  Figure 6A shows representative visual fields 
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of MQAE-labeled neurons, in 3D PDMS (left) and 3D PDMS-GR (right) cultures. As shown in 
Figure 6B (tracings from 2 representative cells), when GABA (10 mM; 10÷20 s) is applied to 
9÷11 DIV cultures, efflux or influx of Cl– are induced in the neurons, depending on their 
maturation, resulting in opposite changes in the Cl– sensitive MQAE fluorescence.[8] In all 
imaged fields (n = 13 for both condition), cells displaying opposite directions of GABA-evoked 
Cl– fluxes were detected, thus confirming that immature and mature GABAergic phenotypes 
coexist within the same network. Anyhow, as shown in the plot of Figure 6B, the majority of 
neurons inside the 3D PDMS responded to GABA applications with a Cl– influx, resulting in a 
decreased fluorescence signal due to dye quenching (plain trace at the bottom) while the 
opposite condition was observed in neurons developed interfaced to the graphene within 
3D PDMS-GR scaffolds (dotted line at the top, striped part of the histograms on the right). 
3. Discussion  
In basic neuroscience, 2D cultures represent a powerful platform that has allowed 
unraveling the mechanistic features of neurons and synapses, yet they are limited tools 
when investigating the role of circuit topology on networks dynamics, for example when 
neuronal branches are exposed to the 3-dimensional space.[2,3] Besides, 3D platforms, when 
compared to 2D ones, were shown to impact neuronal differentiation,[9,43,44] cell and axonal 
growth,[45,46] circuit functional organization and synaptic network synchronization.[2] Further 
engineering of 3D scaffolds into CNS regenerative interfaces may be pursue by the use of 
nanomaterials, such as carbon-based ones, to improve the device electrical conductivity and 
to favor the development of excitable tissue.[7,22,47-49] Here, we exploit elastomeric 3D 
platforms to investigate the impact on network dynamics of posing at the interface few-
layer graphene, known to affect cell signaling when supporting 2D cultures.[8] The 
macroscopic stiffness of the three-dimensional scaffolds we have fabricated was about 60 
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kPa, not so far from compliance values of rodent and human brains (Young’s moduli falling 
in the range of 0.1÷20 kPa).[50] The extremely high values of resistivity of the 3D PDMS-GR 
scaffold (in the MΩ·mm range, at best) despite the presence of few-layers graphene flakes 
(whose electrical resistivity is in the order of 10–6 Ω·mm)[51,52] may result from the combined 
effects of the large contact resistances taking place between contiguous graphene flakes 
and the fact that graphene is not distributed in bulk inside the PDMS but it is randomly 
distributes on the scaffold’s facets. The latter point implicates that the flat gold electrodes 
we used to electrically characterize the material have a minimal contact area with graphene 
being, in the majority, in contact with PDMS, that is an insulator. Importantly, cells inside 
the scaffold developed in contact to the graphene flakes, consequently they locally 
experienced the intrinsic low resistivity of this nanomaterial. This supposition is supported 
by the perturbation of neuronal network electrical activity we observed that is very similar 
to the effect induced on neuronal cells by single layer graphene.[8] 
We successfully reconstructed neuronal networks inside 3D PDMS and 3D PDMS-GR. In both 
growth conditions neurons and GFAP-positive cells percolated the thickness of the scaffolds, 
generating healthy 3D networks of comparable size in the two constructs,[2] being 
hippocampal cell densities and the neuron to glia ratio not affected by graphene layering. 
By live calcium imaging we simultaneously monitor the activity of small groups of neurons. 
We detect episodes of intracellular calcium rise to measure the occurrence of neuronal and 
synaptic activity, a notion supported by TTX experiments.[2] In 3D constructs, neuronal 
calcium episodes are usually due to brief synchronous firing, leading to transient 
synchronization of synaptic events.[2,5] These bursts are accepted index of network 
dynamics,[2,35] even in the absence, in calcium imaging, of single action potential or individual 
synaptic currents resolution. The 3D architecture of synaptic connections sustained a high 
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rate of bursting in 3D PDMS, confirming previous results where we postulated that 3D 
networks topology favors neuronal connectivity efficiency.[2] Spontaneous bursting was 
further increased in 3D PDMS-GR, potentially due to higher neuronal excitability or 
augmented neuronal connectivity, given the substantial similarities in network size with or 
without graphene. Indeed, 2D monoatomic layer of graphene was shown to improve cellular 
excitability via tuning the distribution of extracellular ions at the interface with neurons, 
leading to cell biophysical changes.[8] In accordance, in our experiments with 2D graphene, 
the up-scaled circuit excitability was observed in active cells involved in spontaneous and 
disinhibited bursting. On the contrary, the similar probability of finding spontaneously active 
neurons among 3D PDMS and 3D PDMS-GR fields does not support a mere increase in cell 
excitability or in neuronal connectivity,[2,53] and the slower pace of disinhibited rhythms in 
the presence of graphene is more suggestive of adaptive changes in the excitation/inhibition 
ratio, potentially following graphene interfacing in 3D configurations. We thus favor an 
alternative hypothesis, where the combination between synapse formation under 3D 
architecture and graphene interfaces affected the maturation of GABAergic inhibition, 
tuning the balance between hyperpolarizing and depolarizing responses, the latter acting in 
synergy with glutamate and potentially contributing to network synchronization,[41] in the 
absence of changes in GABAergic phenotype expression.  
Physical interactions between cells and the artificial materials on which they grow may 
influence biological behaviors and trigger growth, maturation or differentiation.[22,47-49,54] In 
the case of 3D PDMS-GR the mechanisms responsible for the (slight) network redistribution 
of inhibition maturation are not known, and might include a complex interplay of 
mechanical, chemical and electrical cues imposed by graphene when cells are able to grow 
in the third dimension. Regardless the need of future mechanistic studies resolving the 
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effects of few-layer graphene in 3D constructs, our report suggests the importance of 
controlling the physicochemical properties of 3D scaffolds for the successful specialized 
guidance of neural network formation and function.  
 
4. Conclusion 
In this work we exploited material science strategies to manufacture 3D scaffolds enabling 
the formation of neuronal circuits in the third dimension. We further introduced, by a simple 
and reproducible procedure, graphene flakes to interface neurons within the three 
dimensional structures. Innovative methods to introduce graphene in interfacing devices 
may improve long-term stability of ultra-sensitive electronic devices. On the other hand, 
graphene and graphene-based materials are attractive nanoplatforms for regenerative 
medicine approaches in neural tissue injury. Within this framework, we describe the ability 
of graphene to modulate neuronal circuit formation when interfaced in the third dimension. 
The possibility to govern cell neurobiology by nanomaterials physical and topographical 
properties can be of interest in future 3D regenerative interfaces for long term medical 
developments. 
5. Experimental Section  
Graphene preparation and characterization 
Graphene used for the scaffold preparation was obtained by a ball-milling protocol, as 
previously described.[25] Briefly, 7.5 mg of graphite (Bay Carbon, Inc. – USA) and 22.5 mg of 
melamine (Sigma-Aldrich), were ball-milled at 100 rpm for 30 minutes using a Retsch PM 
100 planetary mill (Retsch Technology GmbH, Germany) under air atmosphere. The resulting 
solid was dispersed in water (20 mL), obtaining a dark suspension. Melamine was afterwards 
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removed by washing with hot water and a precipitate consisting in poorly exfoliated graphite 
was removed from the liquid fraction after stabilization for 5 days.  
The obtained graphene was subsequently fully characterized by thermogravimetric analysis 
(TGA), Raman spectroscopy and transmission electron microscopy (TEM) techniques. TGA 
was performed at 10 ºC min-1 under nitrogen flow using a TGA Q50 (TA Instruments).  About 
20 graphene samples were analyzed by Raman spectroscopy using a Renishaw inVia Raman 
microspectrophotometer. The laser wavelength and the objective used were 532 nm and 
100×, respectively. The morphology and the lateral size of so obtained graphene flakes were 
obtained by a Jeol JEM 1011 transmission electron microscope and analyzed using ImageJ 
open-source software to calculate sheets dimensions.[55] 
Samples fabrication and characterization 
Flat glass control (CTRL) substrates were commercial glass coverslips (12x24 mm2) cleaned 
in “piranha solution” (H2SO4:H2O 3:1, 100 mL for 50 coverslips) at 90 °C for 16 hours. Before 
use samples were carefully rinsed with deionized water and let to dry in an oven at 80 °C 
overnight. 
Flat graphene samples (2D GR) were prepared depositing by spray-coating a thin 
homogeneous film of few-layers graphene flakes on glass control substrates (see 
Supplementary Figure 1). Briefly, substrates were placed on a hot plate at 100 °C and were 
sprayed with an ethanol dispersion of graphene flakes (0.05 mg/mL) using a Junior 140 air 
brush (SAGOLA, Spain) until reaching a sheet resistance of about 150 kOhm/⎕. The distance 
between the air brush and the plate was around 20 cm and the nitrogen pressure used to 
spray was 2 bars. The substrates were then placed in an oven at 350 °C for 20 minutes to 
remove any trace of solvent. Finally, sheet resistance and transmittance (550 nm) were 
measured using a 34461A Agilent Bench Multimeter (Agilent Technologies, Inc - US) and a 
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Cary 5000 UV-Vis-NIR spectrophotometer (Agilent Technologies, Inc - US), obtaining final 
graphene films with an average sheet resistance of 30.4 kOhm/⎕ and an average 
transmittance of 37%. Scanning electron microscopy was performed using a Philips XL30 
system after samples were coated with a 3 nm layer of gold (Figure S1). 
Self–standing elastomeric scaffolds (3D PDMS-GR) with all facets decorated with flakes of 
graphene were obtained by shaking overnight and in dry conditions a mixture of graphene 
(30 mg) and sucrose (500 mg, sieved in order to have a granulometry of 125÷250 µm). 
Subsequently, 20 μL of deionized water were added and mixed, obtaining a homogeneously 
wet mixture. The mixture was molded into the desired shape (a 5 mm edge cube), gently 
pressed and dried at 60 °C. Polydimethylsiloxane (PDMS – SYLGARD® 184 Silicone Elastomer 
from Dow Corning) was prepared and layered with a thickness of 5 mm in a glass dish. The 
sugar/graphene solid conglomerate was placed onto the dish and was infiltrated under 
vacuum with PDMS. The cubes were then cured in an oven at 85 °C for 1 hour and cooled at 
room temperature. PDMS excess was trimmed away and the cube was dipped in distilled 
water in order to dissolve the sugar. 3D PDMS control samples were prepared following the 
same protocol but in the absence of graphene. 
Elastomeric scaffold containing few-layer graphene was further characterized by Raman 
spectroscopy. Raman spectra of 3D PDMS-GR were recorded with an InVia Renishaw 
microspectrometer equipped with a 532 nm point-based laser. Power density was kept in 
all cases below 5 mW/µm2 to avoid laser-over heating effects. The obtained spectra were a 
result of probing 25 random locations on the sample. Three-dimensional Raman mappings 
were performed with the 532 nm laser by using the line-based option (streamline), which 
analyzed rectangular slices of sample and depth steps of 1 µm until reaching 10 µm allowing 
to map the G-band intensities in three dimensions. 3D PDMS and 3D PDMS-GR scaffold 
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morphologies were evaluated by means of scanning electron microscopy (SEM) imaging. 
Images were collected on a Gemini SUPRA 40 SEM (Carl Zeiss GmbH, Germany) collecting 
secondary electrons mounting 250 µm thick slices of the bare scaffolds with conductive 
carbon tape (Ted Pella, Inc., USA). Images were acquired at 2.5 keV accelerating voltage. 
Before SEM characterization both samples were Au metalized with a metal sputter coater 
(Polaron SC7620). For the mechanical characterization of the 3D PDMS-GR microporous 
scaffold we performed compressive test. In this, we used cubic samples with a dimension of 
5 mm in side. Tests were performed taking advantage of a Galdabini SUN 500 uniaxial 
microcompression apparatus. Scaffolds were compressed between two circular (20 mm in 
diameter) flat surfaces using a high sensitivity load cell for data acquisition (CTCA10K5, AEP 
Transducers, Italy). All tests were done in air at room temperature. Before starting the test, 
a 50 mN preload was applied to the sample to ensure a good contact between the sample 
and the two pressing surfaces. 10 µm/s constant speed loading cycle was used with a final 
load limit fixed at 1 N. Final compressive displacement was about 2 mm (40%). Each 
representative stress-strain curve was obtained by averaging the results from at least 5 
measurements. Sample stiffness was determined as Young’s Modulus (E) evaluating the 
slope of the linear portion of the stress-strain curve (roughly from 10% to 25% deformation). 
Graphene-based scaffold electrical characteristic was studied placing a 5 mm side size cube 
of the 3D PDMS-GR scaffold between the two conductive coplanar flat electrodes (10×10 
mm2) of a home-made device. The sample was initially squeezed between the two 
electrodes with a constant 50 mN load in order to assure optimal contact. Resistivity was 
assessed using a low current source-meter (KEITHLEY 2601A System SourceMeter) at an 
applied bias voltage of about 20 V. The dependency of the resistance upon deformation was 
determined at steps of 10% up to 60% total deformation. All electrical measurements were 
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carried out at room temperature, in air. The deformation dependent resistivity plot was 
obtained by averaging the results from 3 different samples and was calculated from 
resistance via scaffold’s geometrical characteristics. 
Cell Culture Preparation  
Isolation of primary hippocampal tissue was operated in agreement with the guidance of 
the National Institutes of Health and with the proper international and institutional 
standards for the care and use of animals in research (Italian Ministry of Health, in 
agreement with the EU Recommendation 2007/526/CE). All procedures were approved by 
the local veterinary authorities and performed in accordance with the Italian law (decree 
26/14) and the UE guidelines (2007/526/CE and 2010/63/UE). The animal use was approved 
by the Italian Ministry of Health. All efforts were made to reduce the number of animals 
used and to minimize animal suffering. All the reagents were purchased from Sigma-Aldrich 
if not otherwise indicated. Dissociated hippocampal cultures were prepared from postnatal 
2÷3 days old (P2÷P3) Wistar rats as previously reported.[2,30] Cells were plated on four 
distinct substrates: poly-L-ornithine coated glass coverslips (CTRL) and graphene flakes 
coated glass coverslips (2D GR) or on pristine three-dimensional scaffolds (3D PDMS) and 
three-dimensional, graphene functionalized, scaffolds (3D PDMS-GR). 3D scaffolds were 
sliced with a thickness of about 400 μm and then mounted on the glass coverslips using a 
slight adhesive PDMS layer cured for 1 hour at 120 °C.[2,9] One-hour prior to cell plating, in 
order to promote cell adhesion, 2D GR, 3D PDMS and 3D PDMS-GR samples were exposed 
to low-pressure air plasma (Harrick PDC-32G Plasma Cleaner) for 5 minutes at room 
temperature (20÷22 °C) and finally sterilized with ultraviolet (UV) radiations for 20 
minutes.[2] Cultures were incubated at 37 °C, 5% CO2 in a culture medium consisting of MEM 
(Gibco) containing 35 mM glucose (Carlo Erba Reagents), 15 mM HEPES, 1 mM Apo-
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Transferrin, 48 mM Insulin, 3 mM Biotin, 1 mM Vitamin B12. 500 nM Gentamicin (Gibco) 
was also added to prevent contaminations. Half of the culture medium was renewed two 
days after seeding and then changed every two days. Cultures were grown for 9÷11 days in 
vitro (DIV) and then used for experiments.[2] 
Immunofluorescence 
Cells cultured in 3D PDMS and 3D PDMS-GR Scaffolds were fixed in 4% formaldehyde 
(prepared from fresh paraformaldehyde) in PBS 1× for 30 minutes and 1% glutaraldehyde 
for 1 hour for GABA staining, as previously reported.[56] Cultures were permeabilized for 45 
min with 0.3% Triton-X-100 (Carlo Erba) in PBS and subsequently incubated with primary 
antibodies for 45 minutes at RT. After been washed, samples were finally incubated with 
secondary antibodies for 45 minutes. Samples were mounted with anti-fade medium 
Fluoromount on 1 mm thick microscope glass slides. Neurons were stained with rabbit anti-
β-tubulin III primary antibody (1:500 dilution) and visualized with Alexa® 594 goat anti-rabbit 
as secondary antibody (1:500, Invitrogen). Astrocytes were labeled with mouse anti-GFAP 
primary antibodies (1:250) and visualized with Alexa® 488 anti-mouse in goat as secondary 
antibody (1:500, Invitrogen).  
For GABA immunostaining we used mouse anti-β-tubulin III (1:500) and rabbit anti-GABA 
(1:300 dilution) as primary antibodies while Alexa® 594 goat anti-mouse (1:500) and Alexa® 
488 goat anti-rabbit (1:500 dilution) as secondary antibodies. Nuclei were stained in all 
conditions with 4’,6-diamidino-2-phenylindole (DAPI, 1:200, Invitrogen). Graphene was 
visualized by reflection mode during the confocal acquisition.[57,58] To evaluate the density 
of neurons and astrocytes, images of immunolabeled 3D cultures were acquired using an 
inverted confocal Microscope (Nikon Eclipse Ti, Nikon, Japan) with a 20× objective (0.5 NA, 
PlanFluor, Nikon, Japan) and serial confocal planes (z-stack) were acquired every 1 μm across 
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the entire 3D sections. Moreover, to quantify the percentage of GABA-positive neurons, 
images were acquired with 40× objective (0.75 NA, PlanFluor, Nikon, Japan; z-stack every 
500 nm) from randomly selected fields, and GABA-positive neurons were counted. This value 
was then normalized to the overall number of neurons (β-tubulin III positive cells) for each 
field. Analysis and images reconstruction were accomplished using open-source ImageJ 
software.[55] 
Live cell imaging 
For Calcium (Ca2+) imaging experiments, hippocampal cultures were loaded with cell 
permeable Ca2+ indicator Oregon Green 488 BAPTA-1 AM (Molecular Probes): to the dye 
stock (50 µg), 10 µL of DMSO was added and dissociated cultures were incubated for 45 min 
at 37 °C, 5% CO2 at a final concentration of 4 µM. Subsequently samples were placed in a 
recording chamber mounted on an inverted microscope (Nikon Eclipse Ti-U) and 
continuously perfused at RT and at 5 mL/min with a recording solution of composition (mM): 
150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose (pH adjusted to 7.4 with NaOH; 
osmolarity 300 mOsm). The Oregon Green loaded cultures were observed with a 20× 
objective (PlanFluor, 0.45 NA, Nikon, Japan) using an ORCA-Flash 4.0 V2 sCMOS camera 
(Hamamatsu). Images were acquired at a sampling rate of 6.67 Hz (150 ms exposure time) 
under continuous illumination. The camera was set to operate at 512×512 pixels. The Ca2+ 
dye was excited at 488 nm using an appropriate filters/dichroic cube set and a mercury (Hg) 
lamp (Nikon Intensilight). The excitation light was attenuated by neutral density filters (ND 
32). Images from collected light were acquired by an integrating imaging software package 
(HCImage Live, Hamamatsu). After recording the spontaneous activity of hippocampal 
neurons for 10÷15 minutes, 10 μM bicuculline or 10 μM gabazine (both GABAA antagonist) 
were applied to the bath for 20 minutes. At the end of each experiments, 1 μM TTX (a 
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voltage-gated, fast Na+ channel blocker; Latoxan) was added to the recording solution to 
confirm the neuronal nature of the recorded signals. For each sample we recorded, from 
each field, individual (not overlapping or interfering) 30 ± 12 cells by drawing regions of 
interest (ROIs) around clearly recognizable cell bodies. The corresponding light intensity 
traces were analyzed with Clampfit software (pClamp suite, 10.4 version; Axon Instruments) 
in off-line mode and with Igor Pro Software (6.32 A version; WaveMetrics, Lake Oswego, 
Oregon, USA). We then computed the difference between consecutive onset times, to 
obtain the inter-event interval (IEI). Once we obtained the IEI values from each active cell in 
the field, data were pooled for all fields recorded under the same experimental conditions 
and averaged for further comparison. Intracellular Ca2+ transients were expressed as 
fractional amplitude increase (ΔF/F0, where F0 is the baseline fluorescence level and ΔF is 
the rise over baseline); we determined the onset time of neuronal activation by detecting 
those events in the fluorescence signal that exceed at least five times the standard deviation 
of the noise.[2] The values of cross correlation function (CCF) were evaluated using a home-
made procedure in Igor Pro and used to measure the strength of the correlation between 
cells, i.e. the relative probability that the peaks of calcium transients took place at the same 
time in all the cells of a certain field. For chloride imaging, hippocampal dissociated cultures 
grown within 3D scaffolds were loaded with the fluorescent chloride indicator MQAE (N-[6-
methoxyquinolyl] acetoethyl ester, 1 mM final concentration, from Abcam) diluted in the 
recording solution for 10 minutes at 37 °C.[42] After 10 min washes, each sample was placed 
in a recording chamber mounted on an inverted microscope (Nikon Eclipse Ti-U) and 
observed with a 60× objective (0.7 NA, PlanFluor, Nikon, Japan). Samples were continuously 
perfused at RT and at 5 mL/min with a recording solution (see above the composition). 
Images were acquired using an ORCA-Flash 4.0 V2 sCMOS camera (Hamamatsu) for 1 minute 
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at 5 Hz (200 ms exposure time), the fluorescent chloride indicator was excited at the 365 
nm Hg peak using a UV-2A Nikon filter set; excitation light was attenuated by a neutral 
density filter (ND 16). The imaging system was controlled by the integrating imaging 
software (HCImage Live, Hamamatsu) and the camera was set to operate on 1024 × 1024 
pixels. After 5 seconds from the beginning of the recording, 10 mM GABA was bath-applied 
for 20 seconds in order to evoke chloride influx/efflux through the membrane.  
Image time stacks were analyzed in selected ROI to evaluate the variations in MQAE 
fluorescence intensity. Images were analyzed by ImageJ software (NIH) and the 
corresponding traces were studied with Clampfit software (pClamp suite, 10.4 version; Axon 
Instruments) in off-line mode and with Igor Pro Software (6.32 A version; WaveMetrics, Lake 
Oswego, Oregon, USA). Intracellular Cl– transients were expressed as fractional amplitude 
variations (ΔF/F0) and selected only when exceeding at least five times the standard 
deviation of the noise.[8] 
Statistical Analysis 
All values from samples subjected to the same experimental protocols were pooled together 
and expressed as mean ± s.e.m., with n = number of cells, if not otherwise indicated. 
D'Agostino & Pearson omnibus normality test was applied to evaluate the statistical 
distribution of the data sets. Statistically significant difference between two data sets was 
assessed by Student’s t-test for parametric data and by Mann-Whitney or Kolmogorov-
Smirnov test for non-parametric ones. Statistical significance was determined at p < 0.05, 
unless otherwise indicated. Significance was graphically indicated as follows: * p < 0.05, ** 
p < 0.01, and *** p < 0.001. 
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Figure 1| Physicochemical characterization of the few-layer graphene and the 3D PDMS-Gr 
scaffold used in this study  
A. Thermogravimetric analysis (repeated twice) and B. Raman Spectroscopy (average 
spectrum of at least 20 individual spectra) of the starting few-layers graphene flakes used. 
In C., lateral size distribution of graphene flakes determined from transmission electron 
microscopy (TEM) observations (in the inset a representative image is shown). In D., average 
Raman spectrum obtained from 25 different point measurements performed within a pore 
of a 3D PDMS-GR scaffold. E. Perspective of a G-band intensity Raman 3D mapping of the 
interior of a 3D PDMS-GR pore. The reddest regions evidence the higher presence of 
graphene. In F., stress-strain plots for a 3D PDMS scaffold (in gray) and for a 3D PDMS-GR 
scaffold (in black). Elastic moduli (E) (about 60 kPa in Young’s Modulus for both materials) 
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were determined from the initial linear slope of the corresponding stress-strain curves (in 
red, from A to B strain values, for 3D PDMS; in blue, from A to C strain values for 3D PDMS-
GR). In G., deformation-dependent resistivity measurements of a 5 mm side size cube of 3D 
PDMS-GR scaffold. At the left a sketch of the experimental apparatus used to assess scaffold 
resistivity under variable values of elastic deformation (initial F0 was 50 mN and increased 
until a maximum 60% deformation was achieved); at the right the resistivity vs. deformation 
plot showing a monotonic decrease in resistivity as the scaffold is compressed between the 
two flat contacts. Has to be noted that a minimum 20% deformation has to be reached 
before being able to measure a resistivity value. 
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Figure 2 | Development of primary neurons in 3D PDMS and 3D PDMS-GR scaffolds  
A. Low magnification SEM images of 3D PDMS and 3D PDMS-GR scaffolds (left and right, 
respectively); note the similar morphology and cavity size distribution between the two 
materials. B. Confocal micrographs at low (first row) and high (second row) magnification 
showing hippocampal cultures grown within a 3D PDMS scaffold (left) and a 3D PDMS-GR 
one (right). Cells were immune-stained for neurons (anti β-tubulin III, in red), glial cells (anti 
GFAP, in green) and nuclei (DAPI, in blue). Note the complex growth of neuronal and glial 
processes exposed to the third dimension. To highlight the genuine three-dimensional 
cellular networks developed within the two porous scaffolds lateral z views from the 3D 
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images were shown (third row). C. Bar plots summarizing the neuronal (left) and glial (right) 
cell densities in the two constructs. 
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Figure 3 | Live calcium imaging of network activity in 3D PDMS and 3D PDMS-GR 
A. Snapshots of representative fields of neuronal cultures grown on 3D PDMS and 3D PDMS-
GR stained with the Oregon Green 488-BAPTA-1 AM calcium indicator. Fluorescence 
tracings represent repetitive Ca2+-events spontaneously (plain traces) or bicuculline 
induced (dotted traces) recorded in hippocampal cultures (two sample neurons were 
selected from the same field) in the two culturing conditions (3D PDMS, in green; 3D PDMS-
GR, in red). B. Cumulative probability plots of the distribution of Inter Event Interval (IEI) 
values within 3D PDMS and 3D PDMS-GR neuronal networks in saline solution (left) and upon 
removal of synaptic inhibition by bicuculline (left). ***p < 0.001. 
  




Figure 4 | Live calcium imaging of hippocampal network in 2D controls and 2D-GR 
A. Snapshots of representative fields of hippocampal cultures grown on 2D controls 
(CTRL) and 2D graphene (2D GR) stained with Oregon Green 488-BAPTA-1 AM Ca2+-dye. 
Fluorescence tracings represent repetitive Ca2+-events spontaneously (plain traces) or 
bicuculline induced (dotted traces) recorded in hippocampal cultures (two sample neurons 
were selected from the same field) in the two culturing conditions (CTRL, in blue; 2D GR, in 
orange). B. Cumulative probability plots of the Inter Event Interval (IEI) values distribution in 
CTRL and 2D GR neurons in saline solution (left) and upon removal of synaptic inhibition by 
bicuculline (left). ***p < 0.001. 
  




Figure 5 | Expression of GABA phenotype in 3D PDMS and 3D PDMS-GR cultures 
A. Confocal reconstructions of 3D PDMS (left) and 3D PDMS-GR (right) cultures co-
immunostained against the neuronal marker β-tubulin III (in red) and a phenotypic-specific 
marker anti-GABA (in cyan). Cell nuclei were pointed out by DAPI (in dark blue).  B. Bar plot 
summarizing the percentage of GABA-positive cells within the total neuronal population. 
  




Figure 6 | Live chloride imaging of hippocampal network in 3D PDMS and 3D PDMS-GR 
cultures  
A. Representative visual fields of MQAE-labeled neurons of belonging to neuronal 
networks developed within a 3D PDMS scaffold (left) and a 3D PDMS-GR scaffold (right). B. 
At the left, fluorescent tracings representing chloride efflux (dotted trace corresponding to 
an increase in the detected fluorescence signal) or influx (plain trace corresponding to a 
reduction of the detected fluorescence signal) observed in two different cells, depending on 
their degree of maturation. At the right, a bar plot summarizing the percentage in 3D PDMS 
and in 3D PDMS-GR of neurons responding to GABA application with a chloride influx 
(mature GABAergic neurons, plain areas) or, instead, a chloride efflux (immature GABAergic 
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Figure S1 | SEM pictures of a graphene sprayed substrate at different scales.  
A. Representative SEM micrographs of a flat graphene substrate prepared by spray-coating. 
At the left a low magnification image of the substrate showing the high uniformity of the so 
obtained carpets of graphene flakes; at the right a high magnification image pointing out the 
islands of graphene flakes composing the film. 
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PAPER 2: Graphene oxide (nano)flakes modulation of glutamatergic 
synapses in the amygdala cultured circuits: exploiting synaptic 
approaches to anxiety disorders 
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Ballerini1* 
1 International School for Advanced Studies, SISSA Trieste, Italy 
2 University of Manchester, Manchester, UK 
 




Anxiety disorders (ADs) are nervous system maladies involving changes in the amygdala 
synaptic circuitry, such as an up-regulation of excitatory neurotransmission at glutamatergic 
synapses. In the field of nanotechnology, graphene oxide flakes with small lateral size (s-GO) 
have shown outstanding promise for the manipulation of excitatory neuronal transmission 
with high temporal and spatial precision, thus they are ideal candidates for modulating 
amygdalar glutamatergic transmission. Here, we validated an in vitro model of amygdala 
circuitry for screening tools to target synapses towards ADs future treatments. After one 
week in vitro, dissociated amygdalar neurons reconnected forming functional networks, 
whose development recapitulated that of the tissue of origin in vivo. When acutely applied 
to these cultures, s-GO induced a selective modification of excitatory activity. Such evidence 
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of the interaction between s-GO and amygdalar neurons may ground the exploitation of 
alternative approaches for the therapy of ADs. 
 
INTRODUCTION  
Anxiety disorders (ADs), including phobias and post-traumatic stress disorder, comprise 
diseases whose common features are excessive and enduring fear, anxiety or avoidance to 
situations perceived as a threat by the subject.1 These syndromes are the most prevalent 
type of psychiatric illness in western societies2 and have a significant socio-economic 
burden.3 Studies, both in patients and in animal models of ADs, have indicated as a potential 
mechanistic explanation of these syndromes, the expression of glutamate hyper-activity in 
excitatory synapses of the amygdala.4–8 
Amygdaloid complex is an almond shaped small structure located deeply into the temporal 
lobes of the right and left hemispheres, whose function has been related to the processing 
of emotions such as fear.9 These structures are composed by clusters of nuclei, uniquely 
connected with other intra-amygdalar bodies or encephalic areas.10 This specific wiring is at 
the basis of amygdala functionality, which works as a processor that receives sensory and 
cognitive information from the thalamus and cortex and, upon elaboration of these inputs, 
send diverse outputs to other brain structures, resulting in a range of behavioral/autonomic 
and endocrine responses to various environmental contests.11 The characterization of this 
complex connectivity has been instrumental also in identifying dysfunctional pathways in 
ADs and new therapeutic approaches aimed at manipulating synaptic functions with a high 
spatial-temporal control. To address such demands, innovative and promising tools might 
emerge from nanotechnology developments. 
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Recently, small graphene oxide flakes (s-GO), a type of carbon based nanomaterial 
characterized by reduced lateral size, has been found to interfere selectively with the activity 
of hippocampal glutamatergic synapses.12,13 When delivered in vivo into the hippocampus 
of juvenile rats, this nanomaterial induced a selective, transient and spatially restricted 
modulation of the excitatory synaptic activity.13 
s-GO high spatial and temporal precision in targeting glutamatergic synaptic transmission, 
might be exploited to address the excitatory malfunction of the amygdala, underlying ADs. 
However, to date it is completely unexplored whether s-GO exerts effects on the activity of 
amygdalar neurons. 
The restricted anatomical access to amygdaloid bodies limits specific experimental synaptic 
studies in vivo, thus, more simplified models of amygdala circuitries are needed for fast 
screening of new drugs, molecules and nanomaterials that might have applications for the 
treatment of ADs. In the current work, we developed an in vitro model of amygdalar 
neuronal networks, whose activity was explored by patch clamp recordings. We show that 
after one week in vitro neurons reconnected, forming active synapses, whose characteristics 
underwent to a process of maturation, resembling those occurring in vivo. The acute 
treatment with s-GO of these cultures strongly modulated glutamatergic signaling, 
indicating that the nanomaterial interacted with amygdalar neurons at the level of excitatory 
synapses. Thus, we validated this alternative in vitro model of amygdala for studying the 
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MATERIALS AND METHODS 
Graphene oxide nanosheets  
Graphene oxide sheets of small lateral dimensions were synthesized using a modified 
Hummers method. A detailed description for the preparation and characterization of this 
nanomaterial can be found elsewhere.12,13 
 
Dissociated amygdalar cultures 
Isolation of rat brains was performed in agreement with the Italian law (decree 26/14) and 
the European Union (EU) guidelines (2007/526/CE and  2010/63/UE) and all the procedures 
were authorized by the local veterinary authorities and by the institutional (ISAS) ethical 
committee. The animal use was approved by the Italian Ministry of Health.  
Primary cultures of amygdalar cells were obtained from Wistar rats aged 8-10 days. Brains 
were quickly removed from the skull and placed in fresh ice-cold artificial cerebrospinal fluid 
(ACSF) whose composition was (in mM):  124 NaCl, 24 NaHCO3, 13  glucose, 5 HEPES, 2.5 
KCl, 2 CaCl2, 2 MgSO4 and 1,2  NaPO4H2 with a pH of 7.3-7.4 when saturated with 95% O2 
and 5% CO2.14  
Coronal brain slices (400 μm) including the amygdala complex were cut using a vibratome 
(Leica VT100S) and transferred into a dish containing ice-cold oxygenated ACSF. Under a 
dissecting microscope (Olympus SZ40), the regions containing the amygdalar nuclei were 
isolated using a biopsy punch with a dimeter of 1 mm (Kai Medical, Japan).  
The collected tissue was enzymatically and mechanically dissociated following standard 
protocol.15 Cells were seeded onto poly-L-ornithine-coated glass coverslips at a density of 
800 cells/mm2 and maintained in controlled conditions (at 37 °C, 5% CO2) for 8-12 days.  
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Immunofluorescence  
Cultures were fixed after 8 or 12 days in vitro (DIV) with 4% paraformaldehyde in PBS for 20 
minutes and adding 1% glutaraldehyde in PBS for 1 hour for GABA staining as previously 
reported.16 Cells were permeabilized with Triton X-100 (0.3 %), incubated for 30 minutes at 
room temperature (RT) with primary antibodies and, after being rinsed with PBS, incubated 
with secondary antibodies for 30 min at RT. As primary antibodies, we used mouse 
monoclonal anti-GFAP antibody (Sigma G3893, 1:500 dilution) and rabbit polyclonal anti- β-
tubulin III antibody (Sigma T2200, 1:500 dilution) to label glial cells and neurons 
respectively.12 GABAergic neurons were co-stained with mouse monoclonal anti- β-tubulin 
III antibody (Sigma T8535, 1:500 dilution) and anti-GABA polyclonal antibody produced in 
rabbit (Sigma A2052, 1:300 dilution17). As secondary antibodies, we employed Alexa 594 
goat anti-rabbit (Invitrogen, 1:500 dilution), Alexa 594 goat anti-mouse (Invitrogen, 1:500 
dilution), Alexa 488 goat anti-mouse (Invitrogen, 1:500 dilution) and Alexa 488 goat anti-
rabbit (Invitrogen, 1:500 dilution). Nuclei were marked with DAPI (1:400, Invitrogen). For 
each sample, images of 5 randomly selected fields were acquired using a confocal 
microscope (Nikon Eclipse Ti, Nikon, Japan). Images from three different culture series were 
analyzed with the software ImageJ (NIH). 
 
Electrophysiology 
Patch clamp whole-cell recordings were performed from neurons using glass micropipettes 
with a resistance of 4 ÷ 7 MΩ when filled with the intracellular saline solution composed of 
(mM): 120 K gluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP, pH 7.3 and osmolarity 
300 mOsm. All experiments were performed at RT from cells continuously perfused at 5 
ml/min with the standard extracellular solution containing (mM): 150 NaCl, 4 KCl, 2 CaCl2, 1 
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MgCl2, 10 HEPES, 10 glucose, pH 7.4. All data were recorded by means of a Multiclamp 700B 
patch amplifier (Axon CNS, Molecular Devices) digitized at 10 KHz by pClamp 10 software 
(Molecular Devices LLC, USA). Input resistance and cells capacitance were measured online 
with the membrane test feature of the pClamp software. Spontaneous activity was recorded  
in voltage clamp mode at a holding potential of -56 mV (not corrected for the liquid junction 
potential which was -14 mV).  
Spontaneous postsynaptic currents (PSCs) were analyzed offline using the software 
AxoGraph X (Axograph Scientific), which exploits a detection algorithm based on a sliding 
template. For each recording, all the collected events were averaged and the peak amplitude 
and kinetic properties of the mean current were calculated. The decay time of PSCs was 
calculated by fitting the decaying phase of the current with a mono-exponential function. 
Templates characterized by diverse decay times were used to separate offline glutamate 
AMPA-receptor mediated PSCs (~3 ms) and those mediated by GABAA -receptors (~20 ms) 
Pairs of monosynaptically connected neurons, in which the cells were apart ~100 µm one 
from the other, were recognized by the short latency 2.9 ± 0.3 ms12,18 between the peak of 
the presynaptic neuron and the onset of the evoked PSC (ePSC).  
Using a Picospritzer (PDES-02DX; NPI electronic GmbH, Germany), an injection of 
pressurized air (500 ms, 0.5 PSI) was exploited to deliver a puff of s-GO to the amygdalar 
neurons. The puff pipette was filled with standard saline solution (control) or with s-GO (100 
µg/ml diluted in saline solution) and located at a distance of about 200 μm from the 
recorded cell. Considering 1 ml of extracellular solutions in our recording chamber, we 
estimated that the concentration of s-GO reaching the patch-clamped neurons was at least 
10% of that present in the puff pipette as previously reported.12,13 PSCs were recorded 
before (10 min, baseline) and after (5 min) the local ejection.  




All values from samples subjected to the same experimental protocols were pooled together 
and expressed as mean ± s.e.m. with n = number of neurons, if not otherwise indicated. 
D'Agostino & Pearson omnibus normality test was applied to evaluate the statistical 
distribution of the data sets. Statistically significant difference between two data sets was 
assessed by Student’s t-test or by Mann–Whitney test. Statistical significance was 
determined at P < 0.05. 
 
RESULTS 
To explore the impact of nanomaterials on amygdalar circuitry, in particular on subcellular 
components, such as synapses, we developed a simplified in vitro model of amygdala.  This 
structure was isolated with a high degree of precision from coronal brain slices using a biopsy 
punch. The collected region underwent to a process of enzymatic digestion (see methods), 
then cells were seeded on peptide covered glass coverslips and allowed to develop for 8-12 
DIV. In parallel, the slices from which the amygdalar complexes were isolated were 
processed with Nissl staining, to assess brain structures and confirm the correct anatomical 
sampling of amygdalae (Figure 1A). 
The maturation of amygdalar cultures in vitro was characterized through 
immunofluorescence technique and confocal microscopy. Fixed preparations were 
immunostained for neuronal and glial markers at two different time points of their 
development (8 and 12 DIV) to measure culture size and cell composition (Figure 1B-E). 
Neurons were labelled with antibodies against the specific cytoskeletal components β-
tubulin III (in red) and against glial fibrillary acidic protein (GFAP, in green) to visualize glial 
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cells. Nuclei were marked with DAPI (in blue). As shown by the z-stack reconstructions in 
Figure 1B, glial cell density remained stable between 8 and 12 DIV (at 8 DIV: 110.6 ± 7.8 
cells/mm2 and at 12 DIV:  98.0 ± 5.3 GFAP positive cells/mm2; n = 30 visual fields each 
condition), while neuronal density decreased along with the culture aging (at 8 DIV:  80.3 ± 
4.8 cells/mm2 and at 12 DIV: 64.2 ± 4.3 cells/mm2; P = 0.0131, Figure 1B-C).  We further 
explored the neuronal composition of our cultures by determining the amount of inhibitory 
neurons. To this aim, we co-immunostained cells with antibodies against β-tubulin III (in red) 
and GABA (in light blue, Figure 1D). The amount of double positive cells, identified as 
GABAergic neurons, was not changed between 8 and 12 DIV (42 % and 40 % respectively, n 
= 30 visual fields for each conditions, Figure 1E). Thus, dissociated amygdalar cultures 
appeared healthy and formed by well-differentiated GFAP-positive cells and different 
neuronal phenotypes. Their composition appeared stable over time with the exception for 
a slight, but statistically significant reduction in the number of neurons in older cultures. 
Next, we tested amygdalar circuit activity in vitro by patch clamp recording of basal synaptic 
activity (voltage clamp mode) from single cells which were used as probes to sense inputs 
received by surrounding neurons. Figure 1F shows exemplificative recordings from neurons 
at 8 and 12 DIV, in which the current deflections correspond to spontaneous PSCs (sPSCs). 
sPSCs frequencies were slightly larger, although not significantly, in older cultures (8 DIV: 1.5 
± 0.3 Hz, n = 21; 12 DIV: 2.4 ± 0.4 Hz, n = 41; Figure 1G), while PSCs amplitudes increased in 
older cultures (from 20 ± 1 pA 8 DIV to 30 ± 2 pA 12 DIV; Figure 1H). Such statistically 
significant difference (P = 0.0003) is in agreement with the presence of more mature 
synapses at the end of the second week in vitro. 
In amygdalar cultures, spontaneous synaptic activity was composed by a mixed population 
of fast (~3 ms) and slow (~20 ms) decaying sPSCs. The former were abolished by the 
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application of CNQX (10 µM), an antagonist of glutamate AMPA receptor mediated currents 
(n = 6), while the latter were blocked by treatment with gabazine (10 µM), a GABAA receptor 
antagonist (n = 3). Their kinetic properties together with their pharmacology supports their 
excitatory glutamatergic (EPSCs; fast decaying events) or inhibitory GABAergic (IPSCs; slow 
decaying events) nature. 
The diverse decay times of EPSCs and IPSCs were exploited to isolate them offline (see 
methods). Figure 2A displays examples of fast decaying excitatory and slow decaying 
inhibitory sPSCs, collected from the traces of Figure 1F. The analysis of the EPSCs and IPSCs 
revealed small changes in their frequencies during the maturation of the cultures (EPSCs 
from 1.1 ± 0.3 Hz to 2.1 ± 0.4 Hz; IPSCs from 0.4 ± 0.1 Hz to 0.3 ± 0.1 Hz, 8 and 12 DIV, 
respectively; Figure 2B). However, the amplitudes of both EPSCs and IPSCs resulted 
enhanced in a statistically significant manner in older cultures in respect to younger ones 
(EPSCs from 17 ± 1 pA to 22 ± 1 pA, 8 and 12 DIV, respectively P = 0.008; IPSCs: from 25 ± 3 
pA to 39 ± 3 pA, 8 and 12 DIV, respectively, P = 0.005; Figure 2C). When analyzing the kinetic 
properties of IPSCs and EPSCs separately, we found that the rise and decay times of EPSCs 
both increased during neuronal growth (rise time: from  0.72 ± 0.02 ms to 1.02 ± 0.04 ms, 
from 8 and 12 DIV, respectively, P < 0.0001; decay time: from 2.64 ± 0.16 ms to 3.64 ± 0.18 
ms, 8 and 12 DIV, respectively, P = 0.0042). Conversely, while also the IPSCs rise time became 
longer (from 1.37 ± 0.07 ms to 2.05 ± 0.05 ms, 8 and 12 DIV, P < 0.0001), their decay time 
resulted faster in older cells (from 21.10 ± 1.31 ms to 17.31 ± 0.88 ms, 8 and 12 DIV, P < 
0.0001; Figure 2D). All together these findings indicated that both the excitatory and 
inhibitory components of the network mature during the second week of differentiation in 
vitro. 
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With the exception of IPSCs decay time, all sPSCs kinetic parameters slowed down during 
neuronal growth, a result in accordance with an increase in the electrotonic filtering of 
neurites (e.g. longer neurites), following dimensional growth of single neurons. Indeed, cell 
capacitance, an indirect measure of neuronal size,19 of more mature neurons was increased 
in respect to younger cultures (from 52 ± 3 pF to 61 ± 3 pF, n = 30 and n = 55, 8 and 12 DIV 
respectively, P = 0.031), while the input resistance (from 398 ± 36 MΩ to 413 ± 28 MΩ, 8 
and 12 DIV, Figure 2E) and the resting membrane potential (from -59 ± 2 mV to -63 ± 1 mV, 
8 and 12 DIV, Figure 2F) were similar at the two time points measured.  
In a further set of experiments, we induced in current clamp mode action potentials (APs) 
by injecting neurons with short square pulses of depolarizing currents (Figure 2G). The 
analysis of AP amplitudes (at 8 DIV: 98 ± 4 mV, n = 14, and 12 DIV: 102 ± 2 mV, n = 47) and 
half-widths (at 8 DIV: 3.0 ± 0.2 ms 12 DIV: 3.0 ± 0.2 ms) detected no differences between 
the two culture groups (Figure 2 G-I), suggesting that APs were already mature after one 
week of growth in vitro. 
We further investigated synaptic connectivity at 12 DIV by dual patch clamp recordings  from 
pairs of mono-synaptically connected neurons (Figure 3A): the presynaptic cell was elicited 
to fire APs in current clamp configuration, while the postsynaptic one was simultaneously 
clamped at -56 mV to monitor the presence of an ePSC (Figure 3B, see methods). The 
probability to find monosynaptically connected pairs of neurons was high (75%, n = 36 pairs, 
Figure 3C), indicating an elevated degree of connectivity in the neuronal network. In 
addition, the analysis of ePSCs kinetic features revealed that the majority (93%, n = 29, 
Figure 3D) of synapses activated slow decaying currents (~ 20 ms), identifiable as GABAA 
mediated IPSCs, while only a subset of these (7%) showed fast ePSCs (~3 ms), compatible 
with AMPA receptor mediated EPSCs (Figure 3B). The short-term plasticity of these 
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synapses, evaluated by a pair of stimuli at 20 Hz (see methods), revealed that both excitatory 
and inhibitory connections underwent to short-term depression of ePSCs (ratios between 
the amplitude of the second and first ePSCs were 0.9 ± 0.1 for the excitatory connections 
and 0.7 ± 0.1 for the inhibitory ones; Figure 3B). 
In sum, our electrophysiological characterization showed that after 8 DIV, dissociated 
amygdalar neurons reconnected forming functional synapses, whose activity was further 
modified during the second week of development in vitro, compatibly with the acquisition 
of a more mature phenotype of the culture. We decided to exploit such simplified model to 
test the interaction of s-GO with amygdalar neurons. 
In the last set of experiments, we tested whether s-GO affected synaptic activity as showed 
before for hippocampal culture.12,13 In mature cultures (12 DIV), a puff of solution containing 
s-GO (or saline as control) was pressure-applied through a pipette located at a distance of 
200 μm from a neuron, while its spontaneous activity was monitored in voltage clamp mode 
(Figure 4A). Figure 4B shows that s-GO application (orange arrow) produced a change in 
neuronal activity, while the treatment with saline (black arrow) exerted no effect.  
Magnifications of the traces before and after the puffs (insets in the bottom row of figure 
4B) display that s-GO induced changes in the frequency but not in the amplitude of sPSCs. A 
quantification of these parameters detected a statistically significant increment in the after 
puffs frequencies of sPSCs between saline (n = 12) and s-GO (n = 12) treated neurons (for 
saline-treated: 2.5 ± 0.5 Hz and for s-GO-treated: 5.5 ± 1.1 Hz, P = 0.0447; Figure 4C), while 
the pre-puffs frequencies were similar between the two treatments (for saline-treated: 2.6 
± 0.5 Hz and for s-GO-treated: 4.2 ± 1.0 Hz; figure 4C). No changes were detected in the 
amplitudes of sPSCs due to s-GO application (pre-puff values were 65 ± 16 pA for saline and 
Submitted to Nanomedicine: Nanotechnology, Biology and Medicine 
 
66 ± 13 pA for s-GO; post-puff values were 57 ± 13 pA for saline and 48 ± 6 pA for s-GO; 
Figure 4D).  
To better point out the effect of s-GO, we normalized the post-puff values for the pre-puff 
ones for each cell (Figure 4E). Thus, we observed a change of 78.8% ± 36.5% in sPSCs 
frequency after the puff in s-GO treated neurons (P = 0.0424), on the opposite in saline 
treated cells this difference was not statistically relevant (-1.5% ± 5.0%; Figure 4E). By 
isolating the excitatory and the inhibitory components of the network by means of offline 
analysis, we detected that s-GO induced modifications only in the frequency of EPSCs (for 
saline treated neurons: -0.4% ± 7.3%, and for s-GO treated ones: 130% ± 65.3%, P = 0.0255  
pre vs post in s-GO treated samples;  P = 0.0292 saline vs s-GO; figure 4F), while that of IPSCs 
was unchanged (12.1% ± 14.3%, for saline treated and 15.2% ± 19.5%, for s-GO treated; 
figure 4G). These results showed that this nanomaterial was able to interfere with the 




In the current work, we studied the interaction of s-GO with amygdalar neurons, showing 
that this material can modulate selectively the excitatory glutamatergic transmission in 
neuronal circuits obtained from this brain region. We developed dissociated cultures from 
the amygdalae to better dissect synaptic activity at the single cell level.20,21 In respect to 
previous works,14,22–25 we improved our preparation in terms of purity, due to a more precise 
procedure to explant amygdalae, confirmed by our Nissl staining. 
Cultured amygdalar circuits developed with a slight decrease in neurons during the second 
week in vitro, commonly observed in culture,26 possibly related to a reduced availability of 
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neurotrophic factors in respect to the in vivo condition.27–29 However, despite the slight 
decline in the number of neurons, synaptic circuits seems to mature progressively, as 
indicated by the enhancement in the amplitude of both EPSCs and IPSCs at 12 DIV. 
Also the kinetic properties of sPSCs underwent to modifications in this time window: rise 
times of EPSCs and IPSCs slowed down, while decay times got slower for EPSCs and faster 
for IPSCs. These trends match with those observed in amygdala explants obtained from 
animals at different ages,30 indicating that, in our model, neurons retraced a process of 
physiological maturation. While the speed up of IPSCs decay time is compatible with a 
developmental switch from the α2- to the α1-subunit of GABAA receptors,31 the slowing 
down of the other kinetic properties  may be in part related to electrotonic filtering due to 
the growth of neurons during the maturation. Longer dendrites, indeed, would result in 
slower kinetic properties of sPSCs.32 In agreement with this hypothesis, an increase in cell 
capacitance, an indicator of neuronal dimension, was observed at 12 DIV.19 Conversely, we 
did not detect changes either in the properties of APs or in the resting membrane potentials, 
both reported similar to those of juvenile amygdalar neurons in vivo.33 This confirms that 
our cultures present characteristics of mature amygdalar cells, with synapses undergoing a 
progressive strengthening when re-constructing active contacts in vitro.34,35 
This observation was reinforced by the high connectivity detected by dual patch clamp 
recordings at 12 DIV: to note, the large majority of synaptic connections were GABAergic. 
This might appear controversial respect to the characterization of spontaneous network 
activity, where the frequency of EPSCs was prevalent when compared to that of IPSCs. The 
higher probability to find inhibitory synapses was possibly related to our experimental 
setting (dual recordings from neurons apart 100 µm one to the other), which would favor 
the selection of interneurons.15 
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The contribution of amygdala in shaping behavioural responses to environmental stimuli is 
developmentally regulated,36,37 with complex fear responses consolidating around the third 
postnatal week.38–40 Our electrophysiological characterization showed that, when the tissue 
of origin is collected from adolescent animals (P8-P10) and cells are allowed to differentiate 
in vitro for 8-12 days, cultures have single cell and synaptic features resembling those of in 
vivo amygdalar neurons of juvenile animals. Thus, we developed an easily accessible, 
simplified model of mature amygdala for the study of neuronal circuits, suited for fast 
screening of new drugs/materials/devices. 
We used this system to show that s-GO could modify the synaptic function of amygdalar 
neurons. In fact, we reported that when acutely applied, the nanomaterial induced an 
enhancement in network activity, measured as an increase in the frequency of sPSCs respect 
to the pre-treatment baseline. Such effect was selective for the glutamatergic synapses, 
since s-GO changed the occurrence of EPSCs, but not that of IPSCs. s-GO exert their effect 
modifying the presynaptic release of the neurotransmitter.12,13 In other brain region, the 
prolonged exposure to this nanomaterial resulted in a depletion of glutamate from 
presynaptic terminals, responsible for a decrease in the activity of excitatory synapses.12,13 
Since ADs are characterized by a glutamate mediated hyper-function of the amygdala,4,7,41,42 
s-GO might be exploited as therapeutics for long term impairing of glutamate release, 
ultimately down-regulating specifically this pathologically potentiated excitatory signaling. 
Further experiments will be required to demonstrate that the increase in EPSC frequency 
reported here after s-GO application is only a transient effect and that, upon prolonged 
application, the nanomaterial is effective in reducing amygdalar activity. If the high spatial 
and temporal precision demonstrated by s-GO in downregulating excitatory signaling in 
other brain regions will be preserved in the amygdala, this nanomaterial might be a powerful 
Submitted to Nanomedicine: Nanotechnology, Biology and Medicine 
 
alternative tool for the modulation of selective glutamatergic circuits whose activity is 
aberrant in ADs. 
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FIGURE LEGENDS 
FIGURE 1: Dissociated amygdalar neurons reconstruct functional networks in vitro 
(A) Schematic representation of dissociated amygdalar culture procedure: brains isolated 
from adolescent rats are sliced (left); amygdaloid nuclei are precisely isolated by a biopsy 
punch (in green) and enzymatically dissociated to get pure cultures (right). The remaining 
tissue is stained with Nissl procedure (middle) to confirm the sampling of the amygdalae. (B) 
Confocal images of cultures at 8 (left) and 12 (right) DIV, stained with β tubulin III (in red), 
GFAP (in green) and DAPI for nuclei (in blue). (C) Bar plots summarizing the neuron (left) and 
glial (right) cell densities at 8 and 12 DIV. Note the decrease in neuronal density in cultures 
at 12 DIV. (D) Confocal images of neurons double stained with β tubulin III (in red) and GABA 
(in light blue) at 8 and 12 DIV. (E) Bar plots summarize the percentage of GABAergic neurons 
(double-positive cells) at the two time points. (F). On the top, representation of patch clamp 
recording from single cell. Below, exemplificative traces of spontaneous network activity 
recorded from amygdalar neurons after 8 and 12 DIV. Bar plots showing the frequency (G) 
and the amplitude (H) of sPSCs at 8 and 12 DIV.  
In all bar plots, dots superimposed to the bars are single values and * P < 0.05.  
 
FIGURE 2: Electrophysiological characterization of amygdalar neurons 
(A) Offline PSCs analysis of fast-EPSCs (left) and slow-IPSCs (right) at 8 and 12 DIV. Bar plots 
showing the frequencies (B) and the amplitudes (C) of EPSCs and IPSCs at the two considered 
temporal points. The amplitudes of both the types of currents are increased in more mature 
cultures. (D) Summary graphs of EPSC and IPSC kinetic properties at 8 (black circle) and 12 
(blue square) DIV. (E) Summary graph of input resistance and cell capacitance at 8 (black 
circle) and 12 (blue square) DIV. Capacitance becomes larger in more mature neurons. (F) 
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Bar plots summarizing the neuronal resting membrane potential at the two temporal points. 
(G) Representative traces of action potentials in neurons at 8 (black) and 12 (blue) DIV 
neurons, elicited by current injection (the protocol is shown below). Bar plots summarizing 
the AP amplitudes (H) and half-width (I) in the two conditions.  
In all bar plots dots superimposed to the bars are single values and * P < 0.05. 
 
 
FIGURE 3: Electrophysiological characterization of unitary postsynaptic currents at 12 DIV 
(A) Sketch of the experimental setting for pair recordings. (B) Currents injections (above, 4 
ms, 1 nA@20Hz) elicit action potentials in the presynaptic neuron (middle). Below, 
representative averaged traces of evoked unitary EPSCs or IPSCs recorded from postsynaptic 
neurons. (C) Bar plot summarizing the percentage of monosynaptically coupled pairs at 12 
DIV. (D) Histograms showing the percentage of different type of connections in 
monosynaptically coupled pairs.  
 
FIGURE 4: Acute application of s-GO interferes with glutamatergic activity of amygdalar 
neurons (A) Sketch of the experimental setting. (B) Top, representative traces of the 
spontaneous synaptic activity during acute application of saline (left) or s-GO (right). Arrows 
represent the puff ejection (see methods). Bottom, magnified traces of the spontaneous 
synaptic activity recorded before and after saline (left) and s-GO (right) applications. Box 
plots summarize the sPSC frequency (C) and amplitude (D) before and after the acute 
application of saline (black) and s-GO (orange). sPSCs frequency is increased only by 
treatment with s-GO. Summary graphs of the change in sPSCs (E), sEPSCs(F) and sIPSCs (G) 
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frequency after the saline (black circle) and s-GO (orange square) puff. s-GO affect 
selectively the frequency of EPSCs. * P < 0.05.  
  


























Modern medicine witnesses a great need for new and original therapies to cope with the 
growing demand of more effective and safer treatments for pathological conditions (Bramini 
et al., 2018).  
Nanotechnology might offer exiting possibilities for biomedical applications, such as using 
engineered nanomaterials for drug and gene delivery (Bhirde et al., 2009; Chen et al., 2015; 
Maeda-Mamiya et al., 2010), imaging and diagnostics (De La Zerda et al., 2008; Ghosh et al., 
2014) or tissue engineering (Bosi et al., 2015; Thalhammer et al., 2010). Among all 
nanomaterials, graphene and its derivates have attracted an increasing attention in 
biomedical applications, in particular in neuroscience, in the last few years (Kostarelos et al., 
2017; Reina et al., 2017). This attention is mainly due to GBNs extraordinary physicochemical 
features such as thermo-electrical conductivity, mechanical flexibility, transparency and 
good biocompatibility.  
However, before to exploit GBNs into potential therapeutic application, a deeper 
understanding of the interaction between GBNs and the intricate system underlying neural 
cell functions and signaling is crucial. In fact, GBNs, interfacing with cellular and subcellular 
structures, might alter complex biological processes including the neuronal synaptic 
transmission.   
In this context, throughout my PhD I studied different neuron-nanomaterial interactions 
which results show the ability of promising GBNs, in particular single layer graphene and 
graphene oxide, to modulate the sophisticated neural circuit machinery. 
In the first work, we showed, exploiting elastomeric 3D scaffolds, the ability of graphene to 
alter the neuronal circuit formation into 3D hippocampal cultures. In particular, we 
hypothesized that the development of the neuronal network in a 3D environment and in 
presence of graphene altered the maturation of GABAergic inhibition leading to changes in 
excitatory/inhibitory balance.  
This peculiar impact on networks dynamics was not observed neither in 3D PDMS cultures 
nor in 2D graphene one underlying the complex interaction between graphene and cells 
when they are able to grow in third dimension.  
 
 
Despite the fact that future studies are needed to deeper understand the effect of graphene 
in 3D configuration, our work underlines the possibility to exploit nanomaterials and their 
physical and topographical features to modulate the neuronal network for future biomedical 
applications.  
In the second work, we reported the ability of s-GO nanosheets to modulate selectively the 
excitatory glutamatergic transmission of isolated amygdala neurons when acutely applied, 
evaluated as an increment in the spontaneous EPSC frequency if compared with the 
baseline. These results have been obtained upon a detailed characterization, by 
immunofluorescence and electrophysiological techniques, of dissociated amygdala cultures 
which allowed us to better study the synaptic activity at the single cell level (Godfrey et al., 
1975).  
Based on previous published works, the prolonged application of s-GO to hippocampal 
neurons led to a decrease in glutamatergic synaptic activity due to a depletion of the 
neurotransmitter from the presynaptic compartment (Rauti et al., 2016, 2019).  
In this context, it might be possible that the increment of ESPC frequency after the acute s-
GO application is only a transient effect and that, as a result of a prolonged exposure, the 
graphene derivate is capable of downregulating the neuronal activity.  
Surely, more experiments are needed however, if the selective ability of s-GO to alter the 
glutamatergic synapsis reported in other brain regions will be confirmed in the amygdala, 
this nanomaterial might be considered as an innovative tool for biomedical applications.  
In particular, s-GO could be adopted for the selective modulation of the glutamatergic 
circuits whose physiological activity is altered in ArDs (Cortese and Phan, 2005; Wierońska 
et al., 2011).  
Summarizing, the results obtained during my PhD program brought new and interesting 
characterizations about the peculiar interactions between neurons and GBNs which might 
be useful for future research studies, both in vitro and in vivo, and for the development of 
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